Introduction
============

Lung cancer is the most common cancer and the leading cause of cancer-related death in humans worldwide.[@b1-dddt-9-937],[@b2-dddt-9-937] There were about 1.8 million new cases diagnosed with lung cancer in 2012, accounting for 12.9% of the total cases of cancer.[@b1-dddt-9-937],[@b2-dddt-9-937] Small-cell lung cancer and non-small cell lung cancer (NSCLC) are the two major types of lung cancer. NSCLC is the most common type, accounting for 70%--85% of all cases of lung cancer. In the USA, there were 207,339 new cases of lung cancer and 156,953 deaths resulting from lung cancer in 2011,[@b3-dddt-9-937] and it is estimated that there were 224,210 new cases of lung cancer and 159,260 deaths due to lung cancer in 2014.[@b4-dddt-9-937] In the People's Republic of China, lung cancer is the most common cancer and the leading cause of cancer-related death, with a skyrocketing increase in incidence and mortality rates.[@b2-dddt-9-937],[@b5-dddt-9-937] In 2009, the incidence rate for lung cancer was about 53.57/100,000, accounting for 18.74% of overall new cases of cancer; the mortality rate for lung cancer was about 45.57/100,000, accounting for 25.24% of cancer-related deaths.[@b2-dddt-9-937],[@b5-dddt-9-937] Current therapies for lung cancer include surgery, chemotherapy, radiotherapy, immunotherapy, and targeted therapy, which are used alone or in combination. However, the therapeutic outcome for lung cancer is often disappointing, in particular for advanced NSCLC,[@b6-dddt-9-937],[@b7-dddt-9-937] due to the poor response to current therapeutics, drug resistance, and severe side effects, which highlights an urgent need for discovery of efficacious and safe new agents for the treatment of NSCLC.

5,6-Dimethylxanthenone-4-acetic acid (DMXAA, [Figure 1](#f1-dddt-9-937){ref-type="fig"}), also known as vadimezan and ASA404, is a vascular-disrupting agent that reduces the blood supply to tumoral tissue, resulting in tumor regression.[@b8-dddt-9-937],[@b9-dddt-9-937] However, the molecular targets and exact mechanisms of action of DMXAA are elusive so far. DMXAA shows inhibitory effects against several protein kinases, with the most potent effects being on the vascular endothelial growth factor receptor tyrosine kinase family.[@b10-dddt-9-937],[@b11-dddt-9-937] DMXAA is a potent inducer of tumor necrosis factor-α and activates host immune effectors that assist in killing cancer cells.[@b10-dddt-9-937] DMXAA induces rapid vascular collapse and subsequent tumor hemorrhagic necrosis via induction of apoptosis in tumor vascular endothelial cells and indirect vascular effects induced by various cytokines, in particular, tumor necrosis factor-α, serotonin, and nitric oxide.[@b10-dddt-9-937] The pharmacokinetics of DMXAA has also be investigated. In cancer patients, DMXAA concentration-time profiles are well described by a three-compartment model with saturable elimination.[@b12-dddt-9-937] Body surface area and sex are significant covariates on the volume of distribution of the central compartment and the maximum elimination rate, respectively.[@b12-dddt-9-937] DMXAA is extensively metabolized in human liver microsomes and cancer patients. There are two major metabolites of DMXAA, ie, DMXAA acyl glucuronide and 6-hydroxymethyl-5-methylxanthenone-4-acetic acid (6-OH-MXAA). Cytochrome P450 1A2 is responsible for the conversion of DMXAA to 6-OH-MXAA, with an apparent *K*~m~ of 6.2 μM and a V~max~ of 0.014 nmol/minute/mg.[@b13-dddt-9-937] DMXAA is also extensively metabolized by uridine 5′-diphospho-glucuronosyltransferase 1A2 (UGT1A2) and UGT2B7, with a greater contribution from UGT2B7.[@b14-dddt-9-937] DMXAA has been tested mainly in the treatment of NSCLC, and also in prostate cancer and human epidermal growth factor receptor 2-negative breast cancer.[@b15-dddt-9-937]--[@b20-dddt-9-937] In these clinical studies, DMXAA is used alone and more often in combination with other cytotoxic drugs. A Phase II clinical trial showed that DMXAA in combination with carboplatin and paclitaxel had a potent anticancer effect in NSCLC patients.[@b15-dddt-9-937] This triple combination therapy prolonged the survival of about 5 months when compared with the monotherapy.[@b15-dddt-9-937] However, the Phase III clinical trial conducted by Lara et al showed that the triple chemotherapy of DMXAA with carboplatin and paclitaxel failed to improve the efficacy of the monothera-py.[@b16-dddt-9-937] This may be due to the complexity of the mechanisms of action of DMXAA. DMXAA has been shown to target the stimulator of interferon gene (STING) pathway and this effect is only observed in mice but not in humans.[@b21-dddt-9-937]--[@b23-dddt-9-937] However, this cannot provide a convincing explanation for the failure of DMXAA in the Phase III trial in NSCLC patients. Therefore, it is of great importance to globally understand and uncover the molecular targets and related signaling pathways involved in the anticancer effect of DMXAA and DMXAA-based combination therapies.

So far, there are many studies on the mechanisms of action of DMXAA in the treatment of NSCLC, showing that DMXAA can activate STING-dependent innate immune pathways and mitogen-activated protein kinases and inhibit vascular endothelial growth factor receptor.[@b11-dddt-9-937],[@b21-dddt-9-937]--[@b23-dddt-9-937] However, there is a lack of evidence to depict the global molecular targets and related signaling pathways for the NSCLC cell killing effects of DMXAA, such as cell proliferation, programmed cell death, and cell migration and invasion. Notably, targeting cell cycle progression, apoptosis, autophagy, and epithelial to mesenchymal transition (EMT) has been proposed for treatment of NSCLC.[@b24-dddt-9-937] Therefore, an approach that can evaluate cellular proteomic responses to the DMXAA is important for the optimal treatment of NSCLC. Stable-isotope labeling by amino acids in cell culture (SILAC) is a practical and powerful approach to uncovering the global proteomic response to drug treatment and other interventions.[@b25-dddt-9-937] In particular, it can be used to systemically and quantitatively assess the target network of drugs, to evaluate drug toxicity, and to identify new biomarkers for the diagnosis and treatment of important diseases, including NSCLC.[@b25-dddt-9-937]--[@b27-dddt-9-937] In this regard, we investigated the molecular targets of DMXAA in A549 cells using a combination of proteomic and functional approaches, with a focus on cell cycle distribution, apoptosis, autophagy, and redox homeostasis.

Materials and methods
=====================

Chemicals and reagents
----------------------

DMXAA (purity ≥ 98%), ^13^C~6~-L-lysine, L-lysine, ^13^C [@b15-dddt-9-937]6 N4-L-arginine, L-arginine, RNase A, propidium iodide, Dulbecco's phosphate-buffered saline (PBS), heat-inactivated fetal bovine serum (FBS), dialyzed FBS, and Roswell Park Memorial Institute (RPMI)-1640 medium for SILAC were purchased from Sigma-Aldrich Co. (St Louis, MO, USA). The 5-(and 6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate (CM-H~2~DCFDA) was sourced from Invitrogen Inc. (Carlsbad, CA, USA). A FASP™ protein digestion kit was purchased from Protein Discovery Inc. (Knoxville, TN, USA). RPMI-1640 medium for general cultural use was obtained from Corning Cellgro Inc. (Herndon, VA, USA). The polyvinylidene difluoride membrane was purchased from EMD Millipore Inc. (Bedford, MA, USA). Proteomic quantitation kits for acidification, desalting, and digestion, ionic detergent compatibility reagent, a Pierce bicinchoninic acid protein assay kit, and Western blotting substrate were obtained from Thermo Fisher Scientific Inc. (Waltham, MA, USA). Primary antibodies against human cytochrome c, cleaved caspase 3, microtubule-associated protein 1A/1B-light chain 3-I (LC3-I), LC3-II, and beclin 1 were all purchased from Cell Signaling Technology Inc. (Beverly, MA, USA). The antibody against human β-actin was obtained from Santa Cruz Biotechnology Inc. (Dallas, TX, USA).

Cell line and cell culture
--------------------------

The A549 NSCLC cell line was obtained from American Type Culture Collection (Manassas, VA, USA) and cultured in RPMI-1640 medium supplemented with 10% heat-inactivated FBS. The cells were maintained at 37°C in a 5% CO~2~/95% air humidified incubator. DMXAA was dissolved in dimethyl sulfoxide at a stock concentration of 20 mM and stored at −20°C. It was freshly diluted to predetermined concentrations with culture medium. The final concentration of dimethyl sulfoxide was 0.05% (v/v). The control cells received the vehicle only.

Quantitative proteomic study using SILAC
----------------------------------------

Quantitative proteomic experiments were performed using a SILAC-based approach as described previously.[@b25-dddt-9-937],[@b26-dddt-9-937],[@b28-dddt-9-937] Briefly, A549 cells were cultured in RPMI-1640 medium (for SILAC) with (heavy) or without (light) stable isotope-labeled amino acids (^13^C~6~ L-lysine and ^13^C~6~ ^15^N~4~ L-arginine) and 10% dialyzed FBS. A549 cells cultured in heavy medium were treated with 10 μM DMXAA for 24 hours after six cell doubling times. After treatment with DMXAA, A549 cell samples were harvested and lysed with hot lysis buffer (100 mM Tris base, 4% sodium dodecyl sulfate \[SDS\], and 100 mM dithiothreitol). The cell lysate was denatured at 95°C for 5 minutes and then sonicated for 3 seconds with six pulses. The samples were then centrifuged at 15,000× *g* for 20 minutes at room temperature and the supernatant was collected. The protein concentration was determined using ionic detergent compatibility reagent. Subsequently, equal amounts of heavy and light protein samples were combined to reach a total volume of 30--60 μL containing 300--600 μg protein. The combined protein sample was digested using an filter-aided sample prep (FASP™) protein digestion kit. After digestion, the resulting sample was acidified to a pH of 3 and desalted using a C~18~ solid-phase extraction column. The samples were then concentrated using a vacuum concentrator at 45°C for 120 minutes, and the peptide mixtures (5 μL) were subjected to the hybrid linear ion trap (LTQ Orbitrap XL™, Thermo Fisher Scientific Inc.). Liquid chromatography-tandem mass spectrometry was performed using a 10 cm long, 75 μm (inner diameter) reversed-phase column packed with 5 μm diameter C~18~ material having a pore size of 300 Å (New Objective Inc., Woburn, MA, USA) with a gradient mobile phase of 2%--40% acetonitrile in 0.1% formic acid at 200 μL per minute for 125 minutes. The Orbitrap full mass spectrometry scanning was performed at a mass (*m/z*) resolving power of 60,000, with positive polarity in profile mode (M + H^+^). The peptide SILAC ratio was calculated using MaxQuant version 1.2.0.13. The SILAC ratio was determined by averaging all peptide SILAC ratios from peptides identified of the same protein. The proteins were identified using Scaffold 4.3.2 (Proteome Software Inc., Portland, OR, USA) and the pathway was analyzed using ingenuity pathway analysis (IPA) from QIAGEN Inc. (Redwood City, CA, USA).

Cell cycle analysis using flow cytometry
----------------------------------------

The effect of treatment with DMXAA on the cell cycle was determined by flow cytometry as described previously.[@b29-dddt-9-937] Briefly, A549 cells were treated with DMXAA at concentrations of 0.1, 1, and 10 μM for 24 hours. In separate experiments, A549 cells were treated with 10 μM DMXAA over a 72-hour period. The cells were suspended, fixed in 70% ethanol, washed in PBS, and resuspended in 1 mL of PBS containing 1 mg/mL RNase A and 50 μg/mL propidium iodide. The cells were incubated in the dark for 30 minutes at room temperature. Next, the cells were subject to cell cycle analysis using a flow cytometer (BD LSR II Analyzer; Becton Dickinson Immunocytometry Systems, San Jose, CA, USA). The flow cytometer collected 10,000 events for analysis.

Measurement of intracellular reactive oxygen species (ROS) levels
-----------------------------------------------------------------

Intracellular levels of ROS were measured by a fluorometer using CM-H~2~DCFDA according to the manufacturer's instructions. Cell-permeant CM-H~2~DCFDA passively diffuses into cells and is retained in the cells after cleavage by intracellular esterases. Upon oxidation by ROS, the nonfluorescent CM-H~2~DCFDA is converted to highly fluorescent CM-DCF. Briefly, A549 cells were seeded into a 96-well plate at a density of 1×10^4^ cells/well. After treatment with DMXAA at 0.1, 1, and 10 μM for 48 hours, the cells were incubated with CM-H~2~DCFDA at 5 μM in PBS for 30 minutes. The fluorescence intensity was detected at wavelengths of 485 nm (excitation) and 530 nm (emission). The control cells were treated with vehicle only (0.05% dimethyl sulfoxide, v/v).

Western blotting analysis
-------------------------

A549 cells were washed with pre-cold PBS after 24-hour treatment with DMXAA at 0.1, 1, and 10 μM, lysed with radioimmunoprecipitation (RIPA) buffer containing the protease inhibitor and phosphatase inhibitor cocktails, and centrifuged at 3,000× *g* for 10 minutes at 4°C. Protein concentrations were measured using a Pierce bicinchoninic acid protein assay kit. An equal amount of protein sample (30 μg) was resolved by SDS polyacrylamide gel electrophoresis (PAGE) sample loading buffer and electrophoresed on 12% SDS-PAGE minigel after thermal denaturation at 95°C for 5 minutes. The proteins were transferred onto an Immobilon polyvinylidene difluoride membrane at 400 mA for 1 hour at 4°C. Membranes were blocked with skim milk and probed with the indicated primary antibody overnight at 4°C and then blotted with appropriate horseradish peroxidase-conjugated secondary anti-mouse or anti-rabbit antibody. Visualization was performed using a ChemiDoc™ XRS system (Bio-Rad, Hercules, CA, USA) with enhanced chemiluminescence substrate, and the blots were analyzed using Image Lab 3.0 (Bio-Rad). The protein level was normalized to the matching densitometric value of the internal control β-actin.

Statistical analysis
--------------------

The data are presented as the mean ± standard deviation (SD). Comparisons of multiple groups were evaluated by one-way analysis of variance (ANOVA) followed by Tukey's multiple comparison procedure. Values of *P*\<0.05 were considered to be statistically significant. Assays were performed at least three times independently.

Results
=======

Overview of proteomic response to DMXAA treatment in A549 cells
---------------------------------------------------------------

To reveal the potential molecular targets of DMXAA in the treatment of NSCLC, we conducted proteomic experiments to evaluate the interactome of DMXAA in A549 cells. There were 588 protein molecules identified as potential molecular targets of DMXAA in A549 cells, with 281 protein molecules being upregulated and 306 protein molecules being downregulated ([Table 1](#t1-dddt-9-937){ref-type="table"}). Subsequently, these proteins were subjected to IPA. The results showed that 256 signaling pathways and 184 cellular functional proteins were regulated by DMXAA in A549 cells ([Tables 2](#t2-dddt-9-937){ref-type="table"} and [3](#t3-dddt-9-937){ref-type="table"}). These functional proteins were involved in a number of important cellular processes, including cell proliferation, redox homeostasis, cell metabolism, cell migration and invasion, cell survival, and cell death. The signaling pathways included the G~1~ and G~2~ checkpoint regulation pathways, the phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR)signaling pathway, the 5′-AMP-activated protein kinase (AMPK) signaling pathway, the nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated oxidative stress response pathway, the epithelial adherens junction signaling pathway, regulation of the epithelial-mesenchymal transition signaling pathway, the nuclear factor-κB signaling pathway, and the apoptosis signaling pathway. The IPA results showed that the top ten targeted signaling pathways were the eukaryotic initiation factor (eIF) 2 signaling pathway, mTOR signaling pathway, eIF4 and p70S6K signaling pathway, epithelial adherens junction signaling pathway, remodeling of epithelial adherens junctions pathway, Nrf2-mediated oxidative stress response signaling pathway, RhoA signaling pathway, integrin signaling pathway, Rho-mediated regulation of actin-based motility signaling pathway, and Fcγ receptor-mediated phagocytosis signaling pathway ([Table 2](#t2-dddt-9-937){ref-type="table"}).

DMXAA modulates networked signaling pathways in A549 cells
----------------------------------------------------------

As seen in [Figures 2](#f2-dddt-9-937){ref-type="fig"} and [3](#f3-dddt-9-937){ref-type="fig"}, DMXAA showed an ability to regulate a number of networked signaling pathways that have critical roles in the regulation of cellular processes. IPA classified the top ten networks of signaling pathways responding to DMXAA in A549 cells ([Table 4](#t4-dddt-9-937){ref-type="table"}). These signaling networks have important roles in pathophysiological functions and the development of many important diseases. They included gene expression, DNA replication, recombination and repair, protein synthesis, small molecule biochemistry, carbohydrate metabolism, lipid metabolism, energy production, cellular response to therapeutics, connective tissue development and function, cellular assembly and organization, cellular compromise, cell morphology, free radical scavenging, cell death and survival, neurological disease, skeletal and muscular disorders, cardiac damage, cardiac fibrosis, development and function of cardiovascular system, and development of cancer.

DMXAA modulates important regulators involved in cell cycle distribution in A549 cells
--------------------------------------------------------------------------------------

It has been reported that regulation of cell cycle distribution is an effective approach in the treatment of lung cancer,[@b24-dddt-9-937] and that vascular-disrupting agents exhibit modulating effects on cell cycle distribution. However, it has not been fully uncovered the molecular targets and underlying mechanisms of DMXAA. Therefore, in order to explore the effect and potential molecular targets of DMXAA on cell cycle distribution in A549 cells, we treated A549 cells with 10 μM DMXAA for 24 hours and then subjected samples of the cells to quantitative proteomic analysis. The proteomic results showed that DMXAA had an effect on the regulation of cyclins and the cell cycle distribution at G~1~/S and G~2~/M DNA damage checkpoints in A549 cells with the involvement of a number of functional proteins, such as PPP2R1A, RPL5, and SKP1 ([Table 2](#t2-dddt-9-937){ref-type="table"}). These findings suggest that DMXAA may modulate cell cycle distribution, contributing to its anticancer effect.

DMXAA regulates apoptosis and autophagy in A549 cells
-----------------------------------------------------

Apoptosis and autophagy are two predominant programmed cell death pathways.[@b30-dddt-9-937] Manipulating apoptosis and autophagy has been considered to be a promising strategy in the treatment of cancer via the regulation of mitochondria-dependent/-independent pathways.[@b31-dddt-9-937]--[@b35-dddt-9-937] As shown in [Table 2](#t2-dddt-9-937){ref-type="table"}, DMXAA regulated the apoptotic signaling pathway, mitochondrial function, and death receptor signaling pathway, involving a number of functional proteins. These included ACIN1, CYCS, ACTB, AKT2, GSR, PRDX3, SOD2, and VDAC2 ([Table 2](#t2-dddt-9-937){ref-type="table"}). Further, the mTOR signaling pathway plays a pivotal role in the regulation of autophagy, and has been proposed to be a promising target in the treatment of NSCLC.[@b36-dddt-9-937] Vascular disruption combined with mTOR inhibition showed an enhanced anticancer effect when compared with monotherapy.[@b37-dddt-9-937] As shown in [Table 2](#t2-dddt-9-937){ref-type="table"} and [Figure 4](#f4-dddt-9-937){ref-type="fig"}, DMXAA showed an ability to modulate the mTOR signaling pathway in A549 cells. The results showed that DMXAA decreased the expression of EIF3C, EIF4B, RHOA, and RPS3A, but increased the expression of AKT2, EIF3E, EIF3F, PPP2R1A, RPS2, RPS8, RPS26, RPS27, and RPSA in A549 cells ([Table 2](#t2-dddt-9-937){ref-type="table"}), suggesting that modulation of mTOR signaling may play an important role in the cancer cell killing effect of DMXAA in A549 cells. Taken together, the results suggest that the regulatory effects of DMXAA on apoptosis, mitochondrial function, and mTOR signaling pathway contribute, at least in part, to the anticancer effect of this drug in the treatment of NSCLC.

DMXAA regulates redox homeostasis involving ROS-mediated and Nrf2-mediated signaling pathways in A549 cells
-----------------------------------------------------------------------------------------------------------

Induction of ROS plays a critical role in the production of cytokines, contributing to the cancer cell killing effect of DMXAA.[@b38-dddt-9-937] However, the regulatory effect of DMXAA on ROS generation-related molecules and signaling pathways is not fully understood. In this study, we observed that DMXAA regulated several critical signaling pathways related to ROS generation and redox homeostasis in A549 cells. Our quantitative proteomic study showed that treatment with DMXAA regulated oxidative phosphorylation, Nrf2-mediated oxidative stress response, and superoxide radical degradation in A549 cells ([Table 2](#t2-dddt-9-937){ref-type="table"} and [Figure 5](#f5-dddt-9-937){ref-type="fig"}). A number of functional proteins were found to be involved in these pathways, including ACTB, CCT7, GSR, GSTO1, NQO1, PTPLAD1, SOD2, STIP1, TXN, and TXNRD1 ([Table 2](#t2-dddt-9-937){ref-type="table"}). Of note, Nrf2-mediated signaling pathways have a critical role in the maintenance of intracellular redox homeostasis in response to various stimuli via regulating antioxidant responsive elements.[@b39-dddt-9-937],[@b40-dddt-9-937] The quantitative proteomic data suggest that modulation of the expression of functional proteins involved in Nrf2-mediated signaling pathways may contribute to the anticancer effect of DMXAA in the treatment of NSCLC.

Taken together, our quantitative proteomic study revealed a number of important functional proteins and associated signaling pathways that are regulated in A549 cells in response to treatment with DMXAA. These cellular signaling pathways play a pivotal role in the regulation of the cell cycle, apoptosis, autophagy, and oxidative stress. In our subsequent validation experiments, we confirmed the effect of DMXAA on cell cycle distribution, apoptosis, autophagy, and ROS generation in A549 cells.

Verification of molecular targets of DMXAA in A549 cells
--------------------------------------------------------

The quantitative proteomic studies described above showed that DMXAA can modulate a number of functional protein molecules and related signaling pathways involved in cell proliferation, invasion and migration, death, and survival. In order to verify the quantitative proteomic data further, we investigated how DMXAA affected cell cycle distribution, apoptosis, autophagy, and redox homeostasis in A549 cells.

DMXAA induces G~1~ arrest in A549 cells
---------------------------------------

To validate the effect of DMXAA on cell growth, the cell cycle distribution was determined in A549 cells using flow cytometric analysis. As shown in [Figure 6](#f6-dddt-9-937){ref-type="fig"}, a concentration-dependent increase in the cell number in G~1~ phase was observed after incubation of A549 cells with DMXAA at 0.1, 1, and 10 μM for 24 hours, with a 1.1-fold, 1.1-fold, and 1.4-fold increase in the number of cells arrested in G~1~ phase, respectively, compared with control cells treated with vehicle only (*P*\<0.001 by one-way ANOVA, [Figure 6A and B](#f6-dddt-9-937){ref-type="fig"}). In contrast, there was a marked decrease in the number of cells in S and G~2~/M phases in A549 cells treated with DMXAA at 0.1, 1, and 10 μM for 24 hours (*P*\<0.01 or *P*\<0.001 by one-way ANOVA, [Figure 6A and B](#f6-dddt-9-937){ref-type="fig"}). Taken together, the results show that DMXAA can regulate the cell cycle distribution, contributing to its anticancer effect in A549 cells. Moreover, the inducing effect of DMXAA on cell cycle arrest further verifies the regulatory action of DMXAA on G~1~ and G~2~ checkpoints as determined by our proteomic study.

DMXAA induces apoptosis and autophagy in A549 cells
---------------------------------------------------

As stated in our proteomic results, treatment with DMXAA induced apoptotic and autophagic responses in A549 cells involving several important signaling pathways. In the mitochondria/cytochrome c-mediated apoptotic pathway, release of cytochrome c from the mitochondria to the cytosol and resultant activation of the caspase cascade are key steps in the apoptosis process.[@b41-dddt-9-937],[@b42-dddt-9-937] Beclin 1 and LC3-I/II are two important markers in the initiation and progression of autophagy and are critical for formation of autophagosomes.[@b43-dddt-9-937],[@b44-dddt-9-937] During the autophagy process, LC3/Atg8 is cleaved at its C-terminus by Atg4 to generate cytosolic LC3-I.[@b45-dddt-9-937] LC3-I is subsequently conjugated to phosphatidylethanolamine, then proteolytically cleaved and lipidated by Atg3 and Atg7 to form LC3-II, which attaches to the membrane of the autophagosome.

To verify the proteomic response to DMXAA with regard to cell death, we performed Western blotting assays to examine the expression of cytochrome c, caspase 3, beclin 1, and LC3-I/II in A549 cells treated with DMXAA. Incubation of A549 cells with DMXAA at 0.1, 1, and 10 μM markedly increased the cytosolic level of cytochrome c by 1.2-, 1.6-, and 1.6-fold, respectively, compared with the control cells (*P*\<0.05 or *P*\<0.01 by one-way ANOVA, [Figure 7A and B](#f7-dddt-9-937){ref-type="fig"}). Cleaved caspase 3 was increased by DMXAA in A549 cells in a concentration-dependent manner. Incubation of A549 cells with DMXAA at 0.1, 1, and 10 μM significantly increased the level of cleaved caspase 3 by 1.3-, 1.4-, and 2.0-fold, respectively, compared with control cells (*P*\<0.05 by one-way ANOVA, [Figure 7A and B](#f7-dddt-9-937){ref-type="fig"}). These results indicate that DMXAA induces a marked increase in the cytosolic level of cytochrome c and activation of caspase 3, eventually leading to apoptotic death in A549 cells.

We further examined the effect of DMXAA on beclin 1 and LC3-I/II expression levels. Treatment of A549 cells with DMXAA for 24 hours significantly increased the expression of beclin 1. There was a 1.5-, 2.1-, and 1.9-fold increase in beclin 1 in A549 cells treated with DMXAA 0.1, 1, and 10 μM, respectively, for 24 hours (*P*\<0.05 by one-way ANOVA, [Figure 7A and B](#f7-dddt-9-937){ref-type="fig"}). Upon activation of LC3-I/II, our Western blotting analysis revealed two clear bands of LC3-I and II in A549 cells after 24 hour treatment with DMXAA ([Figure 7A](#f7-dddt-9-937){ref-type="fig"}). Incubation of DMXAA at 0.1, 1, and 10 μM markedly increased the expression of LC3-I and LC3-II ([Figure 7A and B](#f7-dddt-9-937){ref-type="fig"}). In comparison with the control cells, there was a 1.6-, 1.9-, and 1.6-fold increase in the level of LC3-I, and a 2.1-, 3.3-, and 2.9-fold increase in the level of LC3-II in A549 cells treated with DMXAA 0.1, 1, and 10 μM, respectively, for 24 hours. In addition, the ratio of LC3-II to LC3-I was markedly increased by 1.3-, 1.8-, and 1.8-fold in A549 cells treated with DMXAA 0.1, 1, and 5 μM, respectively (*P*\<0.05 or *P*\<0.01 by one-way ANOVA, [Figure 7A and B](#f7-dddt-9-937){ref-type="fig"}). Taken together, the proteomic and Western blotting results show that DMXAA induces apoptosis and autophagy in A549 cells, contributing to the anticancer effects of DMXAA in the treatment of NSCLC.

DMXAA induces generation of intracellular ROS in A549 cells
-----------------------------------------------------------

As shown in the proteomic results, treatment with DMXAA can regulate intracellular redox homeostasis in A549 cells, which may contribute to the apoptosis-inducing and autophagy-inducing effects of DMXAA. Thus, we determined the effect of DMXAA on intracellular ROS levels in A549 cells. The intracellular levels of ROS were increased 1.1-, 1.1-, and 1.3-fold in a concentration-dependent manner when A549 cells were treated with DMXAA 0.1, 1, and 10 μM for 48 hours (*P*\<0.001 by one-way ANOVA, [Figure 8](#f8-dddt-9-937){ref-type="fig"}). The ROS-inducing effect of DMXAA further confirms its regulatory effect on intracellular redox homeostasis in A549 cells.

Discussion
==========

NSCLC remains a devastating cancer, with the highest incidence and mortality rate, and treatment of the disease remains a major challenge due to the poor efficacy and severe side effects of both standard and new chemotherapeutic agents. There is an increasing interest in new agents and therapies for the treatment of lung cancer. DMXAA, a flavonoid tumor vascular-disrupting agent, has been found to have anticancer activity in vitro and in vivo in the treatment of NSCLC when used alone or in combination. It targets the established tumor blood vessels and inhibits tumor blood flow, resulting in necrosis of solid tumors. It has also been reported that DMXAA can regulate multiple signaling pathways involved in cell cycle progression, apoptosis, autophagy, and ROS generation.[@b11-dddt-9-937],[@b46-dddt-9-937]--[@b51-dddt-9-937] However, the global potential molecular targets and the possible mechanisms involved are not fully identified as yet. In the present study, we showed a comprehensive network of signaling pathways responding to treatment with DMXAA in A549 cells using a quantitative SILAC-based proteomic approach. The network of signaling pathways was mainly involved in cell cycle distribution, cell invasion and migration, redox homeostasis, and cell death. We verified that DMXAA arrested A549 cells in G~1~ phase, promoted apoptosis, induced marked autophagy, and triggered ROS generation.

The SILAC-based proteomic approach can quantitatively and comprehensively evaluate the effect of a given compound and identify its potential molecular targets and related signaling pathways.[@b52-dddt-9-937]--[@b54-dddt-9-937] Previous studies have used this approach in A549 cells and tried to explore the potential molecular targets and possible mechanism for NSCLC therapy.[@b55-dddt-9-937]--[@b63-dddt-9-937] In our study, we used a quantitative SILAC-based proteomic approach to evaluate the responses of A549 cells to treatment with DMXAA. This approach showed that DMXAA regulates a number of functional proteins and molecular signaling pathways involved in cell cycle progression, apoptosis, autophagy, and redox homeostasis in A549 cells, such as PPP2R1A, RPL5, SKP1, ACIN1, CYCS, ACTB, AKT2, GSR, PRDX3, SOD2, VDAC2, EIF3C, EIF4B, RHOA, RPS3A, AKT2, EIF3E, EIF3F, PPP2R1A, RPS2, RPS8, RPS26, RPS27, RPSA, ACTB, CCT7, GSR, GSTO1, NQO1, PTPLAD1, STIP1, TXN, and TXNRD1. The proteomic results suggest that DMXAA may target these molecules to elicit its anticancer effects in the treatment of NSCLC. Notably, we went on to validate the proteomic responses to DMXAA in A549 cells.

We found that DMXAA arrested A549 cells in G~1~ phase in a concentration-dependent manner, and speculated that the possible mechanism of DMXAA with regard to G~1~ arrest in A549 cells might involve a number of key regulators, including p21 Waf1/Cip1, p53, cyclins and cyclin-dependent kinases. p21 is a cyclin-dependent kinase inhibitor regulated by p53, and can bind to the Cdc2-cyclin B1 complex, thereby inducing cell cycle arrest.[@b64-dddt-9-937] Further, cell cycle progression is tightly regulated by cyclins and cyclin-dependent kinases.[@b65-dddt-9-937] Cyclins have no catalytic activity and are inactive in the absence of a partner cyclin. The complex formed by the association of Cdc2 and cyclin B1 plays a major role in the entry of cells into mitosis. Phosphorylation of Cdc2 at Thr161 by cyclin-dependent kinase--activating kinases is essential for the activity of Cdc2 kinase. Phosphorylation of Cdc2 at Thr14 and Tyr15 is catalyzed by Wee1 and Myt1 protein kinases, resulting in inhibition of Cdc2.[@b65-dddt-9-937] During G~2~/M transition, Cdc2 is rapidly converted into the active form by dephosphorylation of Tyr14 and Tyr15, catalyzed by Cdc25 phosphatase. Thus, taking the proteomic and flow cytometric results into consideration, DMXAA-induced cell cycle arrest may occur via regulation of key modulators controlling the G~1~ and G~2~ checkpoints in A549 cells.

The present proteomic study also shows that DMXAA regulated mitochondrial function and cell death. Mitochondrial disruption and subsequent release of cytochrome c initiates the process of apoptosis, with the latter being initiated by proapoptotic members of the Bcl-2 family but antagonized by antiapoptotic members of this family.[@b66-dddt-9-937],[@b67-dddt-9-937] Antiapoptotic members of Bcl-2 can be inhibited by post-translational modification and/or by increased expression of PUMA, which is an essential regulator of p53-mediated cell apoptosis.[@b68-dddt-9-937] In addition, cytochrome c released from the mitochondria can activate caspase 9, which then activates caspase 3 and caspase 7.[@b69-dddt-9-937] In our study, we observed that the cytosolic level of cytochrome c was significantly increased and that caspase 3 was markedly activated after treatment with DMXAA. The activated caspase 3 ultimately induced apoptosis, with a decrease in the Bcl-2 level.

Further, the proteomic results show that DMXAA has a modulating effect on the mTOR signaling pathway. Under optimal growth conditions, activated mTORC1 inhibits autophagy by direct phosphorylation of Atg13 and ULK1 at Ser757.[@b70-dddt-9-937]--[@b72-dddt-9-937] This phosphorylation inhibits ULK1 kinase activity and subsequent autophagosome formation. When the kinase activity of mTORC1 is suppressed, the autophagic machinery is initiated. In the present study, DMXAA induced autophagy in A549 cells as indicated by the increased expression of beclin 1 and the ratio of LC3-II over LC3-I. The amount of LC3-II or the ratio between LC3-II and LC3-I correlates well with the number of autophagosomes. Taken together, the autophagy-inducing effect of DMXAA may contribute to its anticancer activity via regulation of the mTOR signaling pathway.

In addition, our proteomic study showed that DMXAA regulates the Nrf2-mediated signaling pathway, which controls the basal and induced expression of a wide array of antioxidant response element-dependent genes to regulate the physiological and pathophysiological outcomes of exposure to oxidants.[@b40-dddt-9-937],[@b73-dddt-9-937],[@b74-dddt-9-937] We found a significant inducing effect of DMXAA on ROS generation in A549 cells. However, the mechanism of how DMXAA induces ROS generation is unclear. Nrf2 is a nuclear transcription factor that plays a pivotal role in regulation of oxidative stress by modulating the transcription of antioxidant response elements.[@b40-dddt-9-937] It indicates that DMXAA may induce oxidative stress via the Nrf2-mediated signaling pathway. Our results suggest that ROS may have an important role in DMXAA-induced apoptosis and autophagy in A549 cells. However, further studies are needed to elucidate how DMXAA induces generation of ROS and modulates redox homeostasis.

In summary, the quantitative SILAC-based proteomic approach used in this study showed that DMXAA inhibited cell proliferation, predominantly activated the mitochondria-dependent apoptotic pathway and induced autophagy, and increased intracellular levels of ROS in human A549 cells involving a number of key functional proteins and related molecular signaling pathways. This study may provide a clue enabling full identification of the molecular targets and elucidate the underlying mechanisms of DMXAA in the treatment of NSCLC, resulting in an improved therapeutic effect and fewer side effects in the clinical setting.
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![Chemical structure of 5,6-dimethylxanthenone 4-acetic acid (DMXAA).](dddt-9-937Fig1){#f1-dddt-9-937}

![Proteomic analysis revealed the molecular interactome regulated by DMXAA in A549 cells.\
**Notes:** A549 cells were treated with DMXAA 10 μM for 24 hours and the protein samples were subjected to quantitative SILAC-based proteomic analysis. There were 588 protein molecules regulated by DMXAA in A549 cells, with 281 protein molecules being increased and 306 protein molecules being decreased. Red indicates upregulation; green indicates downregulation; brown indicates predicted activation, and blue indicates predicted inhibition. The intensity of green and red molecule colors indicates the degree of downregulation and upregulation, respectively. The solid arrow indicates direct interaction and the dashed arrow indicates indirect interaction.\
**Abbreviations:** DMXAA, 5,6-dimethylxanthenone 4-acetic acid; SILAC, stable-isotope labeling by amino acids in cell culture.](dddt-9-937Fig2){#f2-dddt-9-937}

![Proteomic analysis revealed a network of signaling pathways regulated by DMXAA in A549 cells.\
**Note:** The network of signaling pathways was analyzed by ingenuity pathway analysis according to the 588 protein molecules regulated by DMXAA in A549 cells.\
**Abbreviation:** DMXAA, 5,6-dimethylxanthenone 4-acetic acid; mTOR, mammalian target of rapamycin; ILK, integrin-linked kinase; Nrf2, nuclear factor erythroid 2-related factor 2; eIF, eukaryotic initiation factor; S6K, p70S6 kinase.](dddt-9-937Fig3){#f3-dddt-9-937}

![DMXAA modulates mTOR signaling pathway in A549 cells.\
**Notes:** A549 cells were treated with DMXAA 10 μM for 24 hours and the protein samples were subject to quantitative proteomic analysis. Red indicates upregulation; green indicates downregulation; brown indicates predicted activation. The intensity of green and red molecule colors indicates the degree of downregulation and upregulation, respectively. The solid arrow indicates direct interaction and the dashed arrow indicates indirect interaction.\
**Abbreviations:** DMXAA, 5,6-dimethylxanthenone 4-acetic acid; mTOR, mammalian target of rapamycin; eIF, eukaryotic initiation factor; AKT, protein kinase B; PKC, protein kinase C; TSC, tuberous sclerosis complex; VEGF, vascular endothelial growth factor; HIF, hypoxia-inducible factor; DAG, diacylglycerol; ATG, autophagy-associated protein; PMA, phorbol myristate acetate; PIP2, phosphatidylinositol 4,5-bisphosphate; IRS1, insulin receptor substrate-1; RTK, receptor tyrosine kinase; LKB1, liver kinase B1; REDD1, protein regulated in development and DNA damage response 1; PI3K, phosphatidylinositide 3-kinase; 4EBP, eukaryotic translation initiation factor 4E binding protein 1; INSR, insulin receptor; AMPK, AMP-activated protein kinase.](dddt-9-937Fig4){#f4-dddt-9-937}

![DMXAA regulates Nrf2-mediated signaling pathways in A549 cells.\
**Notes:** A549 cells were treated with DMXAA 10 μM for 24 hours and the protein samples were subjected to quantitative proteomic analysis. Red indicates upregulation and green indicates downregulation. The intensity of green and red molecule colors indicates the degree of downregulation and upregulation, respectively. The solid arrow indicates direct interaction and the dashed arrow indicates indirect interaction.\
**Abbreviation:** DMXAA, 5,6-dimethylxanthenone 4-acetic acid; ER, endoplasmic reticulum; ROS, reactive oxygen species; Nrf2, nuclear factor erythroid 2-related factor 2; SOD, superoxide dismutase; HO-1, heme oxygenase 1; GST, glutathione *S*-transferase; UGT, uridine 5'-diphospho-glucuronosyltransferase; CCT7, chaperonin containing TCP1, subunit 7; CAT, catalase; FMO, flavin-containing monooxygenase; MRP, multi-drug resistance associated protein; PSM, proteasome; VCP, valosin containing protein; UBB, ubiquitin B; HIP2, huntingtin interacting protein 2; TXN, thioredoxin; FTL, ferritin, light polypeptide; ATF4, activating transcription factor 4; BACH1, BTB and CNC homology 1, basic leucine zipper transcription factor 1; ERK, extracellular signal-regulated kinase; HSP, heat shock protein; PMF-1, polyamine-modulated factor 1; NRPB, nuclear restricted protein, BTB domain-like; MAF, v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog; CYP, cytochrome P450; KEAP1, Kelch-like ECH-associated protein 1; MEK2, MAP kinase kinase 2; ASK1, apoptosis signal regulating kinase 1; TAK1, testicular receptor 4; GSK3, glycogen synthase kinase 3; JNK, c-Jun N-terminal kinase 1; CUL3, cullin 3; MEKK, MAP kinase kinase kinase.](dddt-9-937Fig5){#f5-dddt-9-937}

![DMXAA induces G~1~ phase arrest in A549 cells.\
**Notes:** Cell cycle distribution of A549 cells when treated with DMXAA 0.1, 1, or 0 μM for 24 hours. (**A**) Representative DNA fluorescence histograms showing the effect of DMXAA on cell cycle distribution of A549 cells and (**B**) bar graphs showing the percentage of A549 cells in G~1~, S, and G~2~ phases. Data are shown as the mean ± SD of three independent experiments. \*\**P*\<0.01 and \*\*\**P*\<0.001 by one-way analysis of variance.\
**Abbreviation:** DMXAA, 5,6-dimethylxanthenone 4-acetic acid.](dddt-9-937Fig6){#f6-dddt-9-937}

![DMXAA increases the cytosolic level of cytochrome c and activation of caspase 3, and promotes expression of beclin 1, LC3-I, and LC3-II in A549 cells.\
**Notes:** A549 cells were treated with DMXAA 0.1, 1, or 10 μM for 24 hours and protein samples were subjected to Western blotting assay. (**A**) Representative blots of cytosolic cytochrome c, cleaved caspase 3, beclin 1, LC3-I, and LC3-II in A549 cells and (**B**) bar graphs showing the relative levels of cytosolic cytochrome c, cleaved caspase 3, beclin 1, LC3-I, and LC3-II in A549 cells. Data are shown as the mean ± SD of three independent experiments. \**P*\<0.05 and \*\**P*\<0.01 by one-way analysis of variance.\
**Abbreviations:** DMXAA, 5,6-dimethylxanthenone 4-acetic acid; LC3, microtubule-associated protein 1A/1B-light chain 3.](dddt-9-937Fig7){#f7-dddt-9-937}

![DMXAA induces intracellular ROS generation in A549 cells.\
**Notes:** Intracellular ROS level in A549 cells treated with DMXAA 0.1, 1, or 10 μM for 48 hours. Data are shown as the mean ± SD of three independent experiments. \*\*\**P*\<0.01 by one-way analysis of variance.\
**Abbreviation:** DMXAA, 5,6-dimethylxanthenone 4-acetic acid; ROS, reactive oxygen species.](dddt-9-937Fig8){#f8-dddt-9-937}

###### 

The 588 protein molecules regulated by DMXAA (5,6-dimethylxanthenone 4-acetic acid) in A549 cells

  Protein ID/symbol   Molecular weight (kDa)   Normalized heavy/light ratio
  ------------------- ------------------------ ------------------------------
  Q5VXJ5              93.115                   0.036825
  P3C2G               165.71                   0.052938
  K1C10               58.826                   0.090984
  K1C9                62.064                   0.11756
  CB067               73.235                   0.14108
  1433F               28.218                   0.22201
  K1C14               51.561                   0.33079
  K2C1                66.038                   0.3831
  F5H2G2              52.909                   0.43495
  K2C6B               60.066                   0.4391
  MANF                20.7                     0.52102
  F8VVM2              36.161                   0.56761
  APMAP               32.161                   0.59766
  KRT85               55.802                   0.59966
  B4DS13              64.805                   0.60022
  F5H6E3              18.467                   0.62881
  E9PEU4              47.204                   0.65669
  E9PF80              25.3                     0.65828
  F5H3I4              34.557                   0.66102
  AL3A2               54.847                   0.71801
  RAB1B               22.171                   0.71899
  F5GY65              28.494                   0.71909
  ISG15               17.887                   0.71998
  ACACA               257.24                   0.72374
  H90B4               58.264                   0.72926
  K22E                65.432                   0.73358
  F5H0X6              50.435                   0.73677
  F8VSA6              5.8668                   0.73947
  AK1C1               36.788                   0.74328
  RLA1                11.514                   0.74644
  B4DKS8              37.255                   0.75044
  TMOD3               39.594                   0.75127
  BASP1               22.693                   0.75558
  COX2                25.565                   0.77367
  MARCS               31.554                   0.77387
  F8WD96              30                       0.77581
  F5GX11              26.505                   0.77779
  K2C8                53.704                   0.78215
  K1C18               48.057                   0.7824
  FKB1A               11.951                   0.78264
  B4E1K7              33.337                   0.7835
  Q5TCU6              258.08                   0.784
  RL29                17.752                   0.78622
  F8W7P7              72.716                   0.78997
  CHM4B               24.95                    0.79348
  E9PNH1              13.163                   0.79972
  C9JW37              8.8333                   0.79997
  CLCC1               39.837                   0.80061
  B4E241              14.203                   0.80205
  E9PH29              25.838                   0.80339
  NNMT                29.574                   0.80458
  E7ESM6              101.21                   0.80816
  RL36                12.254                   0.80826
  ETFB                27.843                   0.81589
  F5GWR2              26.63                    0.81598
  SC61B               9.9743                   0.81767
  ALDR                35.853                   0.81844
  AK1C2               36.735                   0.81875
  GRHPR               35.668                   0.81892
  PON2                37.996                   0.82002
  B7Z254              47.837                   0.82473
  FRIL                20.019                   0.82759
  ATP5H               18.491                   0.82832
  B4DNJ5              43.368                   0.82967
  HINT1               13.802                   0.83028
  D6RDN3              4.1286                   0.83128
  S10A4               11.728                   0.83154
  CUL4B               102.3                    0.83195
  IDHC                46.659                   0.83275
  E9PDQ8              41.438                   0.83332
  F8W914              37.144                   0.83563
  ANXA4               35.882                   0.83679
  S38A2               45.178                   0.837
  F5H3T8              52.305                   0.84001
  CDC37               44.468                   0.84082
  A6NKT1              56.36                    0.84176
  B4E0X8              66.231                   0.84218
  SMRD2               55.238                   0.84281
  F8WF81              14.275                   0.84585
  RRBP1               108.63                   0.84762
  SFPQ                76.149                   0.85165
  B4DRT4              17.326                   0.85394
  B4DT43              30.025                   0.85426
  KHDR1               44.027                   0.8553
  E9PPQ5              20.723                   0.85913
  D6RFI0              21.504                   0.8613
  CDC42               21.258                   0.86162
  COX41               19.576                   0.86224
  EF1A2               50.47                    0.86292
  SCMC1               51.354                   0.86294
  C9J1T2              9.4459                   0.86457
  GBG12               8.0061                   0.8649
  E9PKD1              47.431                   0.86946
  C9JPV1              12.063                   0.86969
  BLVRB               22.119                   0.86996
  F5H4L5              32.734                   0.87025
  K2C7                51.385                   0.87164
  FKBP3               25.177                   0.87335
  F5H1J1              38.739                   0.87421
  ECH1                35.816                   0.87427
  EFTU                49.541                   0.87443
  AL1A1               54.861                   0.8745
  RAB5C               23.482                   0.8745
  D6RFH4              14.846                   0.87485
  HSPB1               22.782                   0.8751
  G6PD                59.256                   0.87609
  RB11A               24.393                   0.87617
  HCD2                26.923                   0.8781
  CALX                67.567                   0.87892
  B1AHC7              64.075                   0.87955
  F5H7G7              57.342                   0.88015
  CAZA1               32.922                   0.88192
  S100P               10.4                     0.88323
  AK1C3               36.853                   0.88425
  CALR                48.141                   0.88565
  NOP2                88.972                   0.88741
  HMGA1               11.676                   0.88955
  F8W6V8              53.116                   0.88964
  MIF                 12.476                   0.89038
  USMG5               6.4575                   0.89172
  PSB2                22.836                   0.89303
  CBR1                30.375                   0.8935
  SF3B3               44.605                   0.89353
  PRDX5               17.031                   0.89389
  LRRF1               82.688                   0.89483
  B4DQJ8              51.872                   0.89714
  CCNK                41.293                   0.9026
  FSCN1               54.529                   0.90332
  CS021               75.356                   0.90345
  B4E022              62.878                   0.90614
  G3V5P4              16.916                   0.90639
  PDIA4               72.932                   0.90743
  KYNU                52.351                   0.90767
  PRS6B               43.507                   0.90881
  D6RF62              37.111                   0.90967
  S10A6               10.18                    0.91026
  F5GYB8              19.471                   0.91104
  B3KUK2              19.73                    0.91118
  PPIB                23.742                   0.91132
  D6REM6              88.358                   0.91208
  F2Z3A5              40.127                   0.91256
  R13AX               12.134                   0.91339
  SRSF1               22.46                    0.91352
  GRP78               72.332                   0.91353
  F2Z2J9              28.85                    0.91353
  DNJA2               45.745                   0.91354
  RS19                16.06                    0.91521
  RL23A               17.695                   0.91665
  B7Z2V6              37.751                   0.91676
  TMED9               27.277                   0.91682
  IMUP                8.5115                   0.91694
  ENPL                92.468                   0.917
  LKHA4               57.299                   0.91952
  SERC                35.188                   0.91971
  B1AM77              13.475                   0.92027
  F5GYG9              76.233                   0.92196
  D6RF44              12.64                    0.92222
  B4E0R6              109.36                   0.9266
  MDHM                35.503                   0.92738
  RS15                17.04                    0.92751
  AL3A1               50.394                   0.92795
  ATPB                56.559                   0.92872
  Q5T8U3              21.545                   0.93039
  LGUL                19.043                   0.93096
  A8K318              59.177                   0.93162
  CH10                10.932                   0.93233
  CYTB                11.139                   0.9324
  C8KIM0              47.267                   0.93263
  G3V5Q1              27.125                   0.93343
  RS14                16.273                   0.93344
  A6NN01              12.146                   0.93348
  B7Z6M1              65.632                   0.93372
  B3KUB4              31.857                   0.93524
  NUDC                38.242                   0.9354
  FAS                 273.42                   0.93581
  F5GWY2              58.615                   0.93612
  SMD2                13.527                   0.93633
  MDHC                36.426                   0.93699
  B4DIT7              68.648                   0.93774
  D6RFJ8              47.291                   0.9383
  E9PRQ6              15.159                   0.93879
  FIS1                16.937                   0.93901
  SAHH                47.716                   0.93913
  RLA2                11.665                   0.93935
  AATM                47.517                   0.93946
  INF2                134.62                   0.93976
  ATPA                59.75                    0.93996
  HNRPG               42.331                   0.94001
  EIF1                12.732                   0.94212
  C9JPM4              14.553                   0.94439
  ARF1                20.697                   0.94471
  FLNB                275.66                   0.945
  NSF1C               28.522                   0.94549
  CDV3                22.079                   0.94575
  E7EWF1              45.498                   0.94724
  NDKB                30.137                   0.94913
  B1AH77              16.775                   0.95
  H2A1J               13.936                   0.95043
  GDIR1               23.207                   0.95062
  LDHB                36.638                   0.95153
  PA1B3               25.734                   0.95246
  HNRPU               88.979                   0.95295
  G3V3I1              16.645                   0.95297
  F2Z3F8              29.245                   0.95333
  B4DVU3              88.161                   0.95514
  HSP74               94.33                    0.9556
  B4DKM5              27.478                   0.95717
  SPRE                28.048                   0.9575
  B4DEM7              57.645                   0.95821
  F5GX39              13.631                   0.95862
  F5GZ27              85.64                    0.96103
  PRDX1               22.11                    0.96121
  PTBP1               57.221                   0.96124
  F5H667              83.267                   0.9617
  C9JLU1              16.996                   0.96193
  B4DR70              44.812                   0.96206
  SMD1                13.281                   0.9621
  E7EU12              94.863                   0.96289
  E7ETK5              30.611                   0.96294
  B4DXW1              42.003                   0.9639
  RCN1                38.89                    0.96394
  PABP1               61.18                    0.96407
  ANXA1               38.714                   0.96409
  PARK7               19.891                   0.96461
  H12                 21.364                   0.96469
  B7Z6A4              14.854                   0.96516
  F8VNT9              14.265                   0.96517
  E9PKZ0              22.389                   0.96545
  F5H1S2              18.845                   0.96676
  LRC59               34.93                    0.96685
  UGDH                55.023                   0.96807
  TPIS                26.669                   0.96808
  ROA2                37.429                   0.96842
  VDAC1               30.772                   0.96869
  KPYM                57.936                   0.96936
  ANXA5               35.936                   0.96942
  UBE2N               17.138                   0.96961
  ENOA                47.168                   0.97022
  S10AA               11.203                   0.97031
  HN1                 16.014                   0.97056
  PPIA                18.012                   0.9708
  RL12                17.818                   0.97093
  F5GZ16              99.271                   0.97167
  TCPA                60.343                   0.97176
  B4DRF4              36.43                    0.97231
  ILF2                43.062                   0.9728
  PDCD5               14.285                   0.97482
  XPO2                22.67                    0.97527
  RLA0                34.273                   0.9763
  B4DZP4              45.004                   0.97635
  F8W810              50.529                   0.97677
  B3KQT9              54.102                   0.97689
  E5RJR5              18.72                    0.97695
  CAP1                51.901                   0.97716
  A8K3Z3              44.784                   0.97817
  B4DUR8              55.674                   0.9785
  C9JV57              13.025                   0.97853
  E7EMJ6              31.455                   0.97864
  RS17L               15.55                    0.97906
  F5H8J3              75.177                   0.97909
  RS9                 22.591                   0.97946
  LDHA                36.688                   0.97949
  HNRDL               27.191                   0.97974
  B7Z4V2              72.4                     0.98075
  CKAP4               66.022                   0.9808
  PDIA1               57.116                   0.98205
  AT2A2               109.73                   0.98343
  LPPRC               157.9                    0.98408
  TALDO               37.54                    0.98454
  PHB2                33.296                   0.98512
  NBAS                254.81                   0.9852
  F5GY50              32.895                   0.98539
  RS4X                29.597                   0.98585
  B4DPJ8              54.867                   0.98615
  SYEP                170.59                   0.98633
  HNRPC               27.821                   0.98649
  EF1A1               50.14                    0.98718
  D6RG13              25.608                   0.98723
  AK1BA               36.019                   0.98779
  EF1G                50.118                   0.98818
  NAMPT               55.52                    0.98886
  F8VTY8              41.746                   0.98925
  C9JTK6              12.302                   0.9895
  TCPE                59.67                    0.98993
  RS18                17.718                   0.99091
  FKBP4               51.804                   0.99111
  MOES                67.819                   0.99187
  ARP2                44.76                    0.99233
  RS5                 22.876                   0.99268
  RL11                20.124                   0.99323
  F8VRG3              6.4352                   0.99333
  C9JZ20              22.27                    0.99398
  C9JB50              7.888                    0.99449
  DX39A               49.129                   0.9946
  F5GYN4              28.05                    0.99464
  B7Z795              47.709                   0.99535
  B7Z4T9              54.804                   0.99554
  TERA                89.321                   0.99599
  TCP4                14.395                   0.99621
  B4DGN5              46.575                   0.99641
  DBPA                31.947                   0.99662
  ADT2                32.852                   0.99664
  CALM                16.837                   0.99736
  PGK1                44.614                   0.99895
  ECHM                31.387                   0.99951
  MARE1               29.999                   0.99998
  RS7                 22.127                   1
  API5                49.496                   1.0009
  1433G               28.302                   1.0011
  IQGA1               189.25                   1.0015
  B4DDF7              64.181                   1.0018
  LETM1               83.353                   1.0024
  E7EWI9              34.102                   1.0027
  D6RAS3              23.383                   1.0035
  B4DLR8              22.793                   1.0053
  PROF1               15.054                   1.0054
  ALO17               118.43                   1.0056
  RS3                 26.688                   1.0064
  RAB10               22.541                   1.0066
  XRCC5               82.704                   1.0076
  UBA1                117.85                   1.0076
  CH60                61.054                   1.0081
  A6NLM8              16.245                   1.0083
  F8W0A9              40.793                   1.0086
  NONO                54.231                   1.0087
  C9J7S3              19.969                   1.0092
  C1QBP               31.362                   1.0099
  D6RAN4              20.874                   1.0103
  PDC6I               96.022                   1.0107
  B4E3C2              17.094                   1.0115
  MAP4                85.251                   1.0117
  GSTP1               23.356                   1.0129
  RL10A               24.831                   1.0129
  ACTS                42.051                   1.0141
  DHX9                140.96                   1.0146
  PCBP1               37.497                   1.0146
  F5H1W0              55.907                   1.0147
  H33                 15.328                   1.0156
  RS6                 28.68                    1.0164
  G3V279              8.2033                   1.0169
  D6RBT8              23.862                   1.0179
  PRDX6               25.035                   1.0193
  CAND1               136.37                   1.0201
  TCTP                19.595                   1.0203
  B4DDG1              14.121                   1.0204
  C9JCK5              18.607                   1.0216
  PSB3                22.949                   1.022
  MAP1B               270.63                   1.0222
  CN166               28.068                   1.0223
  ACTN4               104.85                   1.0228
  E9PQD7              25.211                   1.0232
  E7EX53              15.722                   1.0241
  B7ZAT2              52.717                   1.026
  PAIRB               42.426                   1.0261
  E9PCY7              47.087                   1.0262
  HNRPK               48.562                   1.0268
  B8ZZQ6              11.758                   1.0272
  ACOC                98.398                   1.0274
  IF5A1               16.832                   1.0284
  B4E335              39.226                   1.0286
  PCNA                28.768                   1.0288
  A6NL93              9.5355                   1.0294
  FLNA                280.01                   1.0304
  Q5JR95              21.879                   1.0308
  C9J9K3              29.505                   1.0309
  E7ETA0              34.028                   1.0312
  TBB4B               49.83                    1.0315
  COF1                18.502                   1.0318
  CLIC1               26.922                   1.0322
  RINI                49.973                   1.0325
  1433E               29.174                   1.033
  C9JF49              6.6566                   1.0331
  RS13                17.222                   1.0332
  GUAA                76.715                   1.0333
  AN32B               22.276                   1.0342
  E9PGI8              20.18                    1.0342
  CLCA                23.662                   1.0345
  DYHC1               532.4                    1.035
  E9PMD7              28.898                   1.035
  1433T               27.764                   1.0354
  E9PEN3              29.353                   1.0367
  CLH1                187.89                   1.0371
  E9PFH8              41.824                   1.0377
  G3V3T3              21.126                   1.0378
  GDIB                50.663                   1.0384
  PALLD               73.321                   1.04
  B1ALW1              9.4519                   1.0404
  A8MUD9              24.433                   1.0407
  NDKA                17.149                   1.0422
  Q2YDB7              16.541                   1.0422
  S10AB               11.74                    1.0434
  QCR2                48.442                   1.0437
  RS10                18.898                   1.0446
  B7Z9L0              52.33                    1.0449
  G3P                 36.053                   1.046
  E7EQR4              65.578                   1.046
  GBLP                35.076                   1.0464
  1433B               27.85                    1.0465
  F5H0N0              37.406                   1.0468
  G6PI                63.146                   1.0478
  E7EUG1              71.178                   1.0499
  EF1B                24.763                   1.0504
  H4                  11.367                   1.0504
  BTF3                17.699                   1.0505
  PGRC2               23.818                   1.0508
  F8W118              24.694                   1.051
  H32                 15.388                   1.0514
  DYL2                10.35                    1.0516
  E9PEC0              32.819                   1.0516
  ALDOA               39.42                    1.0522
  EF2                 95.337                   1.0523
  TBA1C               49.895                   1.0528
  IPYR                32.66                    1.054
  F8VZJ2              15.016                   1.0547
  PRS10               44.172                   1.0559
  F8W7K3              282.14                   1.0567
  H2B1L               13.952                   1.0571
  G3V5B3              19.154                   1.058
  HSP71               70.051                   1.0588
  B2REB8              30.992                   1.0591
  B4DR63              41.167                   1.0595
  RL22                14.787                   1.0599
  ACTN1               103.06                   1.06
  B4E2S7              39.811                   1.0605
  G3V5M3              9.2044                   1.0608
  C9JU56              13.336                   1.061
  B7Z1N6              35.423                   1.0625
  CAN2                79.994                   1.0631
  F8VWC5              18.091                   1.0641
  SODC                15.936                   1.0644
  TBA1B               50.151                   1.0646
  RS16                16.445                   1.065
  C9JD32              9.6694                   1.0658
  VINC                116.72                   1.0668
  RS25                13.742                   1.0671
  A4D177              20.811                   1.0685
  Q5HYE7              20.42                    1.0694
  GLRX3               37.432                   1.0699
  B4E3E8              71.354                   1.0717
  LEG1                14.716                   1.0729
  A8K8G0              22.964                   1.0736
  TPM4                28.521                   1.0744
  F5H897              74.267                   1.0744
  E9PJH8              15.461                   1.0749
  E9PNR9              18.297                   1.0749
  F8W181              25.892                   1.0756
  AIBP                20.43                    1.0758
  HSP7C               70.897                   1.076
  CPNS1               28.315                   1.0764
  ANXA2               38.604                   1.0765
  1433Z               27.745                   1.077
  HS90A               84.659                   1.0771
  C9JKI3              15.928                   1.0779
  HNRPL               64.132                   1.0786
  NPM                 29.464                   1.0788
  AHNK                629.09                   1.079
  F8VYX6              48.46                    1.0796
  EF1D                31.121                   1.0797
  GTF2I               107.97                   1.0801
  D6R9P3              30.302                   1.0806
  PSME1               28.723                   1.0815
  Q8N1C0              59.549                   1.0838
  ADT3                32.866                   1.0863
  B4DY66              19.152                   1.087
  PLEC                531.78                   1.0874
  E7EX81              65.881                   1.0877
  C9J712              9.7982                   1.088
  F6RFD5              15.397                   1.0883
  PSME2               27.401                   1.09
  HS90B               83.263                   1.0909
  F5H4D6              31.451                   1.0914
  B4DR31              58.162                   1.0921
  RS12                14.515                   1.0928
  TADBP               27.972                   1.0948
  B6EAT9              37.277                   1.0972
  RS15A               14.839                   1.0986
  RS20                13.373                   1.1055
  B4E3S0              41.603                   1.108
  RS28                7.8409                   1.1109
  LMNA                74.139                   1.1139
  ROA1                29.386                   1.1144
  PGRC1               21.671                   1.1155
  C9JHS6              5.6564                   1.1161
  Q5TA01              20.938                   1.1186
  TIF1B               79.473                   1.1193
  HNRPM               73.62                    1.1205
  RL19                23.466                   1.1208
  TXNL1               32.251                   1.1218
  RAN                 24.423                   1.1235
  F8W7C6              18.592                   1.1241
  G3XAI4              119.77                   1.1248
  IF4A1               46.153                   1.1252
  VIME                53.651                   1.1263
  F5H0T1              59.777                   1.1272
  C9JFR7              11.333                   1.1279
  E7EPB3              14.558                   1.1287
  DDX5                69.147                   1.1298
  F5H6Q2              13.789                   1.1306
  ITB1                87.445                   1.1347
  B4DP24              29.485                   1.135
  TAGL2               22.391                   1.1361
  B3KS31              41.952                   1.1361
  SPTB2               251.39                   1.1366
  G3V531              44.06                    1.1371
  PYGB                96.695                   1.141
  PRP8                273.6                    1.1413
  DNJA1               44.868                   1.1421
  TBB2B               49.953                   1.1428
  HNRPQ               58.735                   1.1433
  B7Z9C4              35.253                   1.1444
  IMB1                97.169                   1.1455
  F8W0G4              16.637                   1.1455
  KINH                109.68                   1.1465
  F8WBE5              8.8809                   1.1471
  METK2               43.66                    1.1482
  PTRF                33.362                   1.1512
  K6PP                85.595                   1.1514
  B7Z2S5              60.021                   1.1531
  B2RDM2              36.177                   1.1541
  B4DSC0              14.503                   1.1554
  ECHA                82.999                   1.1555
  F8VPF3              14.436                   1.1565
  B0V3J0              26.101                   1.159
  F8VR50              9.7261                   1.1619
  B3KTM6              28.044                   1.1649
  BAF                 10.058                   1.1652
  IF2A                36.112                   1.1676
  Q5H907              55.795                   1.1682
  TPM1                32.876                   1.1693
  IF6                 26.599                   1.1727
  SYTC                83.434                   1.1736
  Q75MH1              12.985                   1.1814
  B4DZI8              99.045                   1.1821
  Q5T4L4              7.3564                   1.1834
  Q5T093              13.439                   1.1877
  H31                 15.404                   1.1882
  Q5VU59              27.174                   1.1982
  TBB4A               49.585                   1.1987
  MYH9                226.53                   1.2006
  IMA2                57.861                   1.2074
  GLSK                65.459                   1.2081
  Q5T7C4              18.311                   1.2156
  C9JFK9              34.759                   1.2186
  G3V153              70.353                   1.223
  PSA7                20.193                   1.2257
  E5RHS5              26.635                   1.2275
  1433S               27.774                   1.2337
  F2Z3D0              8.1111                   1.238
  PSA4                29.483                   1.2384
  B7Z8D3              14.761                   1.2419
  B4E2Z3              55.939                   1.2474
  E9PP21              16.94                    1.25
  ROA0                30.84                    1.2609
  B4DMT5              33.24                    1.2628
  C9K0U8              14.131                   1.2706
  UBP15               112.42                   1.2708
  ML12A               19.794                   1.2917
  LASP1               29.717                   1.2975
  A8MUB1              48.328                   1.2985
  APOL2               37.092                   1.304
  HMOX1               32.818                   1.3048
  PSA3                27.647                   1.312
  TYB10               5.0256                   1.3172
  Q5T4B6              5.1127                   1.3249
  C9IZ41              17.054                   1.3258
  F5H4W0              44.933                   1.331
  LAT1                55.01                    1.3337
  PSB1                26.489                   1.335
  B4DPJ6              17.473                   1.34
  F5H0C8              34.762                   1.3474
  TBB3                50.432                   1.3583
  TBAL3               45.517                   1.4041
  DUT                 17.748                   1.4353
  F8WC15              47.819                   1.4365
  PLIN3               28.157                   1.4972
  F5GWR9              22.218                   1.499
  C9JL85              5.7044                   1.5138
  E7ERP8              31.801                   1.5322
  AAAT                56.598                   1.6533
  RBM3                17.17                    1.7162
  B4DP11              16.476                   1.8007
  MYOF                179.55                   1.9046
  SRP14               14.57                    1.9407
  PLP2                16.691                   NaN
  HNF4A               52.784                   NaN
  YLPM1               241.64                   NaN
  E7EWZ6              111.13                   NaN
  Q5TCU3              32.814                   NaN

###### 

Signaling pathways for target proteins regulated by DMXAA (5,6-dimethylxanthenone 4-acetic acid) in A549 cells

  Ingenuity canonical pathways                                                      −Log*P*    Molecules
  --------------------------------------------------------------------------------- ---------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  eIF2 signaling                                                                    2.11E01    EIF3C, AKT2, RPS3A, RPS27, RPS2, RPL17, RPS8, RPL23, EIF3E, RPL9, RPL7, RPL15, RPL14, RPL8, EIF3F, RPL7A, RPL28, RPS26, RPL5, RPL10, PPP1CA, RPL31, RPL18, RPL13, RPSA
  mTOR signaling                                                                    7.52E00    AKT2, EIF3C, RPS3A, RPS27, RPS2, RPS8, EIF3E, EIF3F, PPP2R1A, RPS26, RHOA, RPSA, EIF4B
  Regulation of eIF4 and p70S6K signaling                                           6.82E00    AKT2, EIF3F, PPP2R1A, EIF3C, RPS3A, RPS26, RPS27, RPS2, RPS8, EIF3E, RPSA
  Epithelial adherens junction signaling                                            5.87E00    AKT2, ACTR3, TUBB6, MYL6, ACTB, RHOA, TUBA4A, CTNNA1, ARPC3, ZYX
  Remodeling of epithelial adherens junctions                                       5.43E00    ACTR3, TUBB6, ACTB, TUBA4A, CTNNA1, ARPC3, ZYX
  Nrf2-mediated oxidative stress response                                           5.05E00    GSR, SOD2, STIP1, ACTB, NQO1, CCT7, TXN, PTPLAD1, TXNRD1, GSTO1
  RhoA signaling                                                                    4.66E00    ACTR3, CFL2, MYL6, EZR, ACTB, RHOA, PFN2, ARPC3
  Integrin signaling                                                                4.62E00    RAC2, AKT2, ACTR3, ARF4, ACTB, RHOA, CAV1, ARPC3, ZYX, TLN1
  Regulation of actin-based motility by Rho                                         4.59E00    RAC2, ACTR3, MYL6, ACTB, RHOA, PFN2, ARPC3
  Fcγ receptor-mediated phagocytosis in macrophages and monocytes                   4.53E00    RAC2, AKT2, ACTR3, EZR, ACTB, ARPC3, TLN1
  Actin cytoskeleton signaling                                                      4.35E00    RAC2, ACTR3, CFL2, MYL6, EZR, ACTB, RHOA, PFN2, ARPC3, TLN1
  Axonal guidance signaling                                                         4.17E00    DPYSL2, RAC2, AKT2, MYL6, PDIA3, TUBA4A, ACTR3, TUBB6, CFL2, RHOA, RTN4, ARPC3, PFN2, PSMD14
  Purine nucleotides de novo biosynthesis II                                        3.88E00    IMPDH2, PAICS, ATIC
  Germ cell-Sertoli cell junction signaling                                         3.83E00    RAC2, TUBB6, CFL2, ACTB, RHOA, TUBA4A, CTNNA1, ZYX
  Protein ubiquitination pathway                                                    3.77E00    PSMA6, PSMC1, UBE2L3, HSPA9, PSMD14, PSMA1, UBC, PSMA2, SKP1, PSMC5
  RhoGDI signaling                                                                  3.6E00     ACTR3, CFL2, MYL6, EZR, ACTB, RHOA, CD44, ARPC3
  Inosine-5′-phosphate biosynthesis II                                              3.57E00    PAICS, ATIC
  Vitamin C transport                                                               3.55E00    TXN, TXNRD1, GSTO1
  Huntington's disease signaling                                                    3.44E00    TGM2, CTSD, AKT2, CYCS, CPLX2, HSPA9, POLR2H, UBC, PSME3
  RAN signaling                                                                     3.28E00    TNPO1, XPO1, IPO5
  Thioredoxin pathway                                                               2.88E00    TXN, TXNRD1
  Superoxide radical degradation                                                    2.88E00    SOD2, NQO1
  Gluconeogenesis I                                                                 2.78E00    ENO2, ME1, ALDOC
  Integrin linked kinase signaling                                                  2.69E00    AKT2, PPP2R1A, CFL2, MYL6, ACTB, RHOA, NACA
  Aryl hydrocarbon receptor signaling                                               2.65E00    TGM2, CTSD, NEDD8, NQO1, PTGES3, GSTO1
  Leukocyte extravasation signaling                                                 2.54E00    RAC2, MYL6, EZR, ACTB, RHOA, CD44, CTNNA1
  Rac signaling                                                                     2.5E00     ACTR3, CFL2, RHOA, CD44, ARPC3
  Gap junction signaling                                                            2.43E00    AKT2, TUBB6, PDIA3, ACTB, CAV1, TUBA4A
  Pentose phosphate pathway                                                         2.33E00    PGD, TKT
  Caveolar-mediated endocytosis signaling                                           2.31E00    ARCN1, ACTB, CAV1, COPB2
  Tight junction signaling                                                          2.28E00    AKT2, PPP2R1A, MYL6, ACTB, RHOA, CTNNA1
  Ephrin receptor signaling                                                         2.19E00    RAC2, AKT2, ACTR3, CFL2, RHOA, ARPC3
  Ceramide signaling                                                                2.15E00    CTSD, AKT2, PPP2R1A, CYCS
  Signaling by Rho family GTPases                                                   2.15E00    ACTR3, CFL2, MYL6, EZR, ACTB, RHOA, ARPC3
  Sertoli cell-Sertoli cell junction signaling                                      2.13E00    AKT2, TUBB6, ACTB, CAV1, TUBA4A, CTNNA1
  Virus entry via endocytic pathways                                                1.99E00    RAC2, ACTB, CAV1, TFRC
  Antioxidant action of vitamin C                                                   1.86E00    PDIA3, TXN, TXNRD1, GSTO1
  Semaphorin signaling in neurons                                                   1.86E00    DPYSL2, CFL2, RHOA
  Actin nucleation by ARP-WASP complex                                              1.79E00    ACTR3, RHOA, ARPC3
  Glutamate biosynthesis II                                                         1.72E00    GLUD1
  Glutamate degradation X                                                           1.72E00    GLUD1
  Glycolysis I                                                                      1.63E00    ENO2, ALDOC
  Mitochondrial dysfunction                                                         1.62E00    GSR, PRDX3, SOD2, CYCS, VDAC2
  14-3-3-mediated signaling                                                         1.59E00    AKT2, TUBB6, PDIA3, TUBA4A
  Pyrimidine ribonucleotide interconversion                                         1.57E00    CMPK1, CTPS1
  Ascorbate recycling (cytosolic)                                                   1.55E00    GSTO1
  Glutathione redox reactions II                                                    1.55E00    GSR
  Thyroid hormone biosynthesis                                                      1.55E00    CTSD
  4-aminobutyrate degradation I                                                     1.55E00    SUCLG2
  Pigment epithelium derived factor signaling                                       1.52E00    AKT2, SOD2, RHOA
  Pyrimidine ribonucleotide biosynthesis de novo                                    1.51E00    CMPK1, CTPS1
  Clathrin-mediated endocytosis signaling                                           1.5E00     ACTR3, ACTB, TFRC, ARPC3, UBC
  Ephrin B signaling                                                                1.49E00    RAC2, CFL2, RHOA
  Breast cancer regulation by stathmin1                                             1.45E00    PPP2R1A, TUBB6, RHOA, TUBA4A, PPP1CA
  Arsenate detoxification I (glutaredoxin)                                          1.43E00    GSTO1
  Uracil degradation II (reductive)                                                 1.43E00    DPYSL2
  2-ketoglutarate dehydrogenase complex                                             1.43E00    DLST
  Thymine degradation                                                               1.43E00    DPYSL2
  Cell cycle regulation by BTG family proteins                                      1.36E00    PPP2R1A, PRMT1
  tRNA splicing                                                                     1.36E00    TSEN34, APEX1
  Pentose phosphate pathway (oxidative branch)                                      1.33E00    PGD
  Glutamate degradation III (via 4-aminobutyrate)                                   1.33E00    SUCLG2
  Focal adhesion kinase signaling                                                   1.3E00     AKT2, ACTB, TLN1
  Docosahexaenoic acid signaling                                                    1.28E00    AKT2, CYCS
  tRNA charging                                                                     1.28E00    RARS, DARS
  Arginine biosynthesis IV                                                          1.25E00    GLUD1
  Pentose phosphate pathway (nonoxidative branch)                                   1.25E00    TKT
  Citrulline-nitric oxide cycle                                                     1.25E00    CAV1
  Death receptor signaling                                                          1.24E00    ACIN1, CYCS, ACTB
  Mechanisms of viral exit from host cells                                          1.24E00    ACTB, XPO1
  Telomerase signaling                                                              1.17E00    AKT2, PPP2R1A, PTGES3
  Hypoxia-inducible factor-1α signaling                                             1.13E00    AKT2, CAV1, APEX1
  Cdc42 signaling                                                                   1.12E00    ACTR3, CFL2, MYL6, ARPC3
  Ephrin A signaling                                                                1.12E00    CFL2, RHOA
  Wnt/β-catenin signaling                                                           1.11E00    AKT2, PPP2R1A, CD44, UBC
  Prostanoid biosynthesis                                                           1.08E00    PTGES3
  Sucrose degradation V (mammalian)                                                 1.08E00    ALDOC
  Ketolysis                                                                         1.08E00    ACAT1
  Sphingosine-1-phosphate signaling                                                 1.07E00    AKT2, PDIA3, RHOA
  Retinoic acid receptor activation                                                 1.06E00    AKT2, RPL7A, PSMC5, PRMT1
  Endometrial cancer signaling                                                      1.06E00    AKT2, CTNNA1
  Ketogenesis                                                                       1.04E00    ACAT1
  Production of nitric oxide and reactive oxygen species in macrophages             1.03E00    AKT2, PPP2R1A, RHOA, PPP1CA
  Lymphotoxin β receptor signaling                                                  1.03E00    AKT2, CYCS
  Hereditary breast cancer signaling                                                1.02E00    AKT2, POLR2H, UBC
  Glutaryl-CoA degradation                                                          1E00       ACAT1
  Gα12/13 signaling                                                                 9.98E-01   AKT2, MYL6, RHOA
  Glioma invasiveness signaling                                                     9.91E-01   RHOA, CD44
  Regulation of cellular mechanics by calpain protease                              9.91E-01   EZR, TLN1
  CD28 signaling in T-helper cells                                                  9.9E-01    AKT2, ACTR3, ARPC3
  ERK/MAPK signaling                                                                9.87E-01   RAC2, PPP2R1A, TLN1, PPP1CA
  Glucocorticoid receptor signaling                                                 9.85E-01   HMGB1, AKT2, HSPA9, POLR2H, PTGES3
  p70S6K signaling                                                                  9.82E-01   AKT2, PPP2R1A, PDIA3
  Myc-mediated apoptosis signaling                                                  9.79E-01   AKT2, CYCS
  High-mobility group box 1 signaling                                               9.74E-01   HMGB1, AKT2, RHOA
  Thrombin signaling                                                                9.63E-01   AKT2, MYL6, PDIA3, RHOA
  Induction of apoptosis by human immunodeficiency virus-1                          9.54E-01   CYCS, SLC25A3
  Xenobiotic metabolism signaling                                                   9.34E-01   PPP2R1A, CES1, NQO1, PTGES3, GSTO1
  Cell cycle: G~1~/S checkpoint regulation                                          9.08E-01   RPL5, SKP1
  Cellular effects of sildenafil (Viagra^®^)                                        9.05E-01   MYL6, PDIA3, ACTB
  Isoleucine degradation I                                                          9.03E-01   ACAT1
  Urate biosynthesis/inosine 5′-phosphate degradation                               9.03E-01   IMPDH2
  Mevalonate pathway I                                                              9.03E-01   ACAT1
  Hypoxia signaling in the cardiovascular system                                    8.97E-01   UBE2L3, NQO1
  Cardiac β-adrenergic signaling                                                    8.76E-01   PPP2R1A, PPP1CA, APEX1
  Chondroitin sulfate degradation (metazoa)                                         8.75E-01   CD44
  Superpathway of citrulline metabolism                                             8.75E-01   CAV1
  Agrin interactions at neuromuscular junction                                      8.55E-01   RAC2, ACTB
  Granzyme B signaling                                                              8.49E-01   CYCS
  Dermatan sulfate degradation (metazoa)                                            8.49E-01   CD44
  Methionine degradation I (to homocysteine)                                        8.49E-01   PRMT1
  Parkinson's signaling                                                             8.49E-01   CYCS
  Renal cell carcinoma signaling                                                    8.35E-01   AKT2, UBC
  Small-cell lung cancer signaling                                                  8.35E-01   AKT2, CYCS
  Endothelial nitric oxide synthase signaling                                       8.22E-01   AKT2, HSPA9, CAV1
  Synaptic long-term depression                                                     8.16E-01   PPP2R1A, PDIA3, CAV1
  Leptin signaling in obesity                                                       8.07E-01   AKT2, PDIA3
  Glutathione redox reactions I                                                     8.02E-01   GSR
  Superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)         8.02E-01   ACAT1
  Cysteine biosynthesis III (mammalia)                                              8.02E-01   PRMT1
  Glioblastoma multiforme signaling                                                 7.91E-01   AKT2, PDIA3, RHOA
  DNA damage-induced 14-3-3σ signaling                                              7.8E-01    AKT2
  Cyclins and cell cycle regulation                                                 7.71E-01   PPP2R1A, SKP1
  Dopamine receptor signaling                                                       7.71E-01   PPP2R1A, PPP1CA
  Granzyme A signaling                                                              7.6E-01    APEX1
  Purine nucleotide degradation II (aerobic)                                        7.6E-01    IMPDH2
  Tryptophan degradation III (eukaryotic)                                           7.6E-01    ACAT1
  C-X-C-motif chemokine receptor-4 signaling                                        7.55E-01   AKT2, MYL6, RHOA
  Polyamine regulation in colon cancer                                              7.23E-01   PSME3
  Pyrimidine deoxyribonucleotide biosynthesis I de novo                             7.23E-01   CMPK1
  Phospholipase C signaling                                                         7.15E-01   TGM2, PEBP1, MYL6, RHOA
  Thyroid hormone receptor/retinoid X receptor activation                           7.14E-01   AKT2, ME1
  Tricarboxylic acid cycle II (eukaryotic)                                          7.05E-01   DLST
  Dopamine-DARPP32 feedback in cAMP signaling                                       7.05E-01   PPP2R1A, PDIA3, PPP1CA
  Cytotoxic T-lymphocyte antigen 4 signaling in cytotoxic T lymphocytes             6.91E-01   AKT2, PPP2R1A
  Gβγ signaling                                                                     6.91E-01   AKT2, CAV1
  Ultraviolet-induced MAPK signaling                                                6.91E-01   CYCS, PDIA3
  Interleukin-22 signaling                                                          6.89E-01   AKT2
  Tumoricidal function of hepatic natural killer cells                              6.89E-01   CYCS
  Crosstalk between dendritic cells and natural killer cells                        6.84E-01   ACTB, TLN1
  p21-activated kinase signaling                                                    6.84E-01   CFL2, MYL6
  Apoptosis signaling                                                               6.84E-01   ACIN1, CYCS
  Triacylglycerol degradation                                                       6.73E-01   CES1
  Vascular endothelial growth factor signaling                                      6.7E-01    AKT2, ACTB
  Lipid antigen presentation by CD1                                                 6.58E-01   PDIA3
  Antiproliferative role of TOB in T-cell signaling                                 6.58E-01   SKP1
  cAMP response element-binding protein signaling in neurons                        6.54E-01   AKT2, PDIA3, POLR2H
  Salvage pathways of pyrimidine ribonucleotides                                    6.49E-01   AKT2, CMPK1
  Interleukin-15 production                                                         6.44E-01   TWF1
  B-cell receptor signaling                                                         6.3E-01    RAC2, AKT2, CFL2
  Glutathione-mediated detoxification                                               6.3E-01    GSTO1
  Amyotrophic lateral sclerosis signaling                                           6.22E-01   CYCS, SSR4
  Calcium signaling                                                                 6.21E-01   MYL6, TPM3, ASPH
  Superpathway of cholesterol biosynthesis                                          6.16E-01   ACAT1
  CDK5 signaling                                                                    6.16E-01   PPP2R1A, PPP1CA
  Nitric oxide signaling in the cardiovascular system                               6.16E-01   AKT2, CAV1
  Interleukin-8 signaling                                                           5.98E-01   RAC2, AKT2, RHOA
  Paxillin signaling                                                                5.98E-01   ACTB, TLN1
  Superpathway of methionine degradation                                            5.91E-01   PRMT1
  Cytotoxic T lymphocyte-mediated apoptosis of target cells                         5.8E-01    CYCS
  Molecular mechanisms of cancer                                                    5.74E-01   RAC2, AKT2, CYCS, RHOA, CTNNA1
  Agranulocyte adhesion and diapedesis                                              5.73E-01   MYL6, EZR, ACTB
  Nerve growth factor signaling                                                     5.68E-01   AKT2, RHOA
  N-formyl-l-methionyl-l-leucyl-phenylalanine signaling in neutrophils              5.63E-01   ACTR3, ARPC3
  Fc epsilon RI signaling                                                           5.57E-01   RAC2, AKT2
  TNF-related weak inducer of apoptosis signaling                                   5.57E-01   CYCS
  Inhibition of angiogenesis by thrombospondin 1                                    5.57E-01   AKT2
  Retinol biosynthesis                                                              5.57E-01   CES1
  Natural killer cell signaling                                                     5.52E-01   RAC2, AKT2
  Role of tissue factor in cancer                                                   5.52E-01   AKT2, CFL2
  Triacylglycerol biosynthesis                                                      5.47E-01   ELOVL1
  Stearate biosynthesis I (animals)                                                 5.47E-01   ELOVL1
  Nucleotide excision repair pathway                                                5.47E-01   POLR2H
  Antigen presentation pathway                                                      5.26E-01   PDIA3
  Protein kinase A signaling                                                        5.21E-01   MYL6, PDIA3, RHOA, PPP1CA, APEX1
  CCR3 signaling in eosinophils                                                     5.15E-01   CFL2, RHOA
  Phosphatase and tensin homolog signaling                                          5.1E-01    RAC2, AKT2
  Netrin signaling                                                                  5.07E-01   RAC2
  Synaptic long-term potentiation                                                   5.05E-01   PDIA3, PPP1CA
  P2Y purigenic receptor signaling pathway                                          5.05E-01   AKT2, PDIA3
  Sperm motility                                                                    5.01E-01   TWF1, PDIA3
  Role of protein kinase R in interferon induction and antiviral response           4.98E-01   CYCS
  PI3K/Akt signaling                                                                4.86E-01   AKT2, PPP2R1A
  Melanoma signaling                                                                4.81E-01   AKT2
  Estrogen receptor signaling                                                       4.68E-01   POLR2H, HNRNPD
  PI3K signaling in B lymphocytes                                                   4.64E-01   AKT2, PDIA3
  Ovarian cancer signaling                                                          4.51E-01   AKT2, CD44
  Cardiac hypertrophy signaling                                                     4.49E-01   MYL6, PDIA3, RHOA
  Role of Oct4 in mammalian embryonic stem cell pluripotency                        4.49E-01   PHB
  Macrophage stimulating protein-RON signaling pathway                              4.49E-01   ACTB
  Insulin receptor signaling                                                        4.39E-01   AKT2, PPP1CA
  Relaxin signaling                                                                 4.35E-01   AKT2, APEX1
  5′-AMP-activated protein kinase signaling                                         4.35E-01   AKT2, PPP2R1A
  TNF receptor-1 signaling                                                          4.27E-01   CYCS
  Cell cycle: G[@b2-dddt-9-937]/M DNA damage checkpoint regulation                  4.27E-01   SKP1
  Assembly of RNA polymerase II complex                                             4.2E-01    POLR2H
  Amyloid processing                                                                4.14E-01   AKT2
  CD27 signaling in lymphocytes                                                     4.07E-01   CYCS
  Interleukin-2 signaling                                                           4.01E-01   AKT2
  Gαq signaling                                                                     3.89E-01   AKT2, RHOA
  Role of checkpoint kinase 1 proteins in cell cycle checkpoint control             3.89E-01   PPP2R1A
  Epidermal growth factor signaling                                                 3.83E-01   AKT2
  Nur77 signaling in T lymphocytes                                                  3.77E-01   CYCS
  Phospholipases                                                                    3.77E-01   PDIA3
  Aldosterone signaling in epithelial cells                                         3.72E-01   PDIA3, HSPA9
  Tec kinase signaling                                                              3.53E-01   ACTB, RHOA
  Estrogen-dependent breast cancer signaling                                        3.5E-01    AKT2
  Granulocyte-monocyte colony stimulating factor signaling                          3.5E-01    AKT2
  Retinoic acid mediated apoptosis signaling                                        3.4E-01    CYCS
  Interleukin-17A signaling in airway cells                                         3.4E-01    AKT2
  Pyridoxal 5′-phosphate salvage pathway                                            3.4E-01    AKT2
  Non-small cell lung cancer signaling                                              3.35E-01   AKT2
  Interleukin-15 signaling                                                          3.3E-01    AKT2
  Angiopoietin signaling                                                            3.3E-01    AKT2
  Mitotic roles of polo-like kinase                                                 3.3E-01    PPP2R1A
  Role of PI3K/Akt signaling in the pathogenesis of influenza                       3.3E-01    AKT2
  Pregnane X receptor/9-cis retinoic acid receptor activation                       3.25E-01   AKT2
  Erythropoietin signaling                                                          3.25E-01   AKT2
  Gamma aminobutyric acid receptor signaling                                        3.25E-01   UBC
  Role of MAPK signaling in the pathogenesis of influenza                           3.21E-01   AKT2
  Macropinocytosis signaling                                                        3.21E-01   RHOA
  Acute phase response signaling                                                    3.2E-01    AKT2, SOD2
  Role of NFAT in regulation of immune response                                     3.15E-01   AKT2, XPO1
  Endothelin-1 signaling                                                            3.12E-01   PDIA3, CAV1
  Melatonin signaling                                                               3.12E-01   PDIA3
  Interleukin-3 signaling                                                           3.07E-01   AKT2
  Chemokine signaling                                                               3.07E-01   RHOA
  Interleukin-17 signaling                                                          3.03E-01   AKT2
  Janus kinase/Stat signaling                                                       3.03E-01   AKT2
  Nuclear factor kappaB activation by viruses                                       2.99E-01   AKT2
  FLT3 signaling in hematopoietic progenitor cells                                  2.95E-01   AKT2
  Toll-like receptor signaling                                                      2.95E-01   UBC
  Dendritic cell maturation                                                         2.94E-01   AKT2, PDIA3
  Role of NFAT in cardiac hypertrophy                                               2.94E-01   AKT2, PDIA3
  Triggering receptor expressed on myeloid cells 1 signaling                        2.91E-01   AKT2
  HER-2 signaling in breast cancer                                                  2.87E-01   AKT2
  VEGF family ligand-receptor interactions                                          2.87E-01   AKT2
  Interleukin-4 signaling                                                           2.87E-01   AKT2
  Acute myeloid leukemia signaling                                                  2.83E-01   AKT2
  Platelet-derived growth factor signaling                                          2.83E-01   CAV1
  Regulation of the epithelial to mesenchymal transition pathway                    2.81E-01   AKT2, RHOA
  1,25(OH)~2~D/retinoid X receptor                                                  2.79E-01   PSMC5
  Role of macrophages, fibroblasts, and endothelial cells in rheumatoid arthritis   2.68E-01   AKT2, PDIA3, RHOA
  Prostate cancer signaling                                                         2.65E-01   AKT2
  Fibroblast growth factor signaling                                                2.55E-01   AKT2
  Neuregulin signaling                                                              2.45E-01   AKT2
  RANK signaling in osteoclasts                                                     2.45E-01   AKT2
  Chronic myeloid leukemia signaling                                                2.3E-01    AKT2
  Stress-activated protein/Janus kinase signaling                                   2.27E-01   RAC2
  Glioma signaling                                                                  2.24E-01   AKT2
  Mouse embryonic stem cell pluripotency                                            2.24E-01   AKT2
  Insulin-like growth factor 1 signaling                                            2.19E-01   AKT2
  p53 signaling                                                                     2.16E-01   AKT2
  Neuropathic pain signaling in dorsal horn neurons                                 2.11E-01   PDIA3
  Cholecystokinin/gastrin-mediated signaling                                        2.08E-01   RHOA
  Hepatocyte growth factor signaling                                                1.98E-01   AKT2

**Abbreviations:** ARP, actin-related protein; cAMP, cyclic adenosine monophosphate; ERK, extracellular signal-regulated kinase; MAPK, mitogen-activated protein kinase; PI3K, phosphatidylinositol-4,5-bisphosphate 3-kinase; NFAT, nuclear factor of activated T-cells; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor; WASP, Wiskott-Aldrich syndrome protein.

###### 

The 184 direct targets of DMXAA (5,6-dimethylxanthenone 4-acetic acid) in A549 cells analyzed by ingenuity pathway analysis

  Protein ID   Symbol     Entrez gene name                                                                                          Location              Type(s)                   Fold change
  ------------ ---------- --------------------------------------------------------------------------------------------------------- --------------------- ------------------------- -------------
  Q5VXJ5       SYCP1      Synaptonemal complex protein 1                                                                            Nucleus               Other                     −27.155
  F8VVM2       SLC25A3    Solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3                             Cytoplasm             Transporter               −1.762
  B4DS13       EIF4B      Eukaryotic translation initiation factor 4B                                                               Cytoplasm             Translation regulator     −1.666
  E9PEU4       ARCN1      Archain 1                                                                                                 Cytoplasm             Other                     −1.523
  F5H3I4       ACTR1A     ARP1 actin-related protein 1 homolog A (yeast)                                                            Cytoplasm             Other                     −1.513
  F5GY65       SLC25A11   Solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11                         Cytoplasm             Transporter               −1.391
  F8VSA6       NEDD8      Neural precursor cell expressed, developmentally down-regulated 8                                         Nucleus               Enzyme                    −1.352
  B4DKS8       HNRNPF     Heterogeneous nuclear ribonucleoprotein F                                                                 Nucleus               Other                     −1.333
  F8WD96       CTSD       Cathepsin D                                                                                               Cytoplasm             Peptidase                 −1.289
  F5GX11       PSMA1      Proteasome (prosome, macropain) subunit, α type, 1                                                        Cytoplasm             Peptidase                 −1.286
  B4E1K7       STOML2     Stomatin (EPB72)-like 2                                                                                   Plasma membrane       Other                     −1.276
  Q5TCU6       TLN1       Talin 1                                                                                                   Plasma membrane       Other                     −1.276
  F8W7P7       WDHD1      WD repeat and HMG-box DNA binding protein 1                                                               Nucleus               Other                     −1.266
  E9PNH1       GANAB      α-Glucosidase; neutral AB                                                                                 Cytoplasm             Enzyme                    −1.250
  C9JW37       PSMD14     Proteasome (prosome, macropain) 26S subunit, non-ATPase, 14                                               Cytoplasm             Peptidase                 −1.250
  B4E241       SRSF3      Serine/arginine-rich splicing factor 3                                                                    Nucleus               Other                     −1.247
  E9PH29       PRDX3      Peroxiredoxin 3                                                                                           Cytoplasm             Enzyme                    −1.245
  B7Z254       PDIA6      Protein disulfide isomerase family A, member 6                                                            Cytoplasm             Enzyme                    −1.213
  B4DNJ5       RPN1       Ribophorin I                                                                                              Cytoplasm             Enzyme                    −1.205
  D6RDN3       CPLX2      Complexin 2                                                                                               Cytoplasm             Other                     −1.203
  E9PDQ8       SUCLG2     Succinate-CoA ligase, GDP-forming, β subunit                                                              Cytoplasm             Enzyme                    −1.200
  F8W914       RTN4       Reticulon 4                                                                                               Cytoplasm             Other                     −1.197
  F5H3T8       RARS       Arginyl-tRNA synthetase                                                                                   Cytoplasm             Enzyme                    −1.190
  B4E0X8       FUBP1      Far upstream element (FUSE) binding protein 1                                                             Nucleus               Transcription regulator   −1.187
  F8WF81       DDB1       Damage-specific DNA binding protein 1, 127 kDa                                                            Nucleus               Other                     −1.182
  B4DT43       ETFA       Electron-transfer-flavoprotein, α polypeptide                                                             Cytoplasm             Transporter               −1.171
  B4DRT4       PEBP1      Phosphatidylethanolamine binding protein 1                                                                Cytoplasm             Other                     −1.171
  E9PPQ5       CHORDC1    Cysteine and histidine-rich domain (CHORD) containing 1                                                   Other                 Other                     −1.164
  D6RFI0       SFXN1      Sideroflexin 1                                                                                            Cytoplasm             Transporter               −1.161
  C9J1T2       RHOA       Ras homolog family member A                                                                               Cytoplasm             Enzyme                    −1.157
  C9JPV1       SLC6A6     Solute carrier family 6 (neurotransmitter transporter), member 6                                          Plasma membrane       Transporter               −1.150
  D6RFH4       CYB5B      Cytochrome b5 type B (outer mitochondrial membrane)                                                       Cytoplasm             Enzyme                    −1.143
  B4DQJ8       PGD        Phosphogluconate dehydrogenase                                                                            Cytoplasm             Enzyme                    −1.115
  B4E022       TKT        Transketolase                                                                                             Cytoplasm             Enzyme                    −1.104
  G3V5P4       CFL2       Cofilin 2 (muscle)                                                                                        Extracellular space   Other                     −1.103
  D6RF62       PAICS      Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase      Cytoplasm             Enzyme                    −1.099
  B3KUK2       SOD2       Superoxide dismutase 2, mitochondrial                                                                     Cytoplasm             Enzyme                    −1.097
  D6REM6       MATR3      Matrin 3                                                                                                  Nucleus               Other                     −1.096
  B7Z2V6       ATP6V1A    ATPase, H^+^ transporting, lysosomal 70 kDa, V1 subunit A                                                 Plasma membrane       Transporter               −1.091
  B1AM77       STOM       Stomatin                                                                                                  Plasma membrane       Other                     −1.087
  D6RF44       HNRNPD     Heterogeneous nuclear ribonucleoprotein D                                                                 Nucleus               Transcription regulator   −1.084
  B4E0R6       IPO5       Importin 5                                                                                                Nucleus               Transporter               −1.079
  Q5T8U3       RPL7A      Ribosomal protein L7a                                                                                     Cytoplasm             Other                     −1.075
  A8K318       PRKCSH     Protein kinase C substrate 80K-H                                                                          Cytoplasm             Enzyme                    −1.073
  C8KIM0       GSR        Glutathione reductase                                                                                     Cytoplasm             Enzyme                    −1.072
  G3V5Q1       APEX1      APEX nuclease (multifunctional DNA repair enzyme) 1                                                       Nucleus               Enzyme                    −1.071
  A6NN01       H2AFV      H2A histone family, member V                                                                              Nucleus               Other                     −1.071
  B7Z6M1       PLS3       Plastin 3                                                                                                 Cytoplasm             Other                     −1.071
  B3KUB4       CA12       Carbonic anhydrase XII                                                                                    Plasma membrane       Enzyme                    −1.069
  F5GWY2       ATIC       5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/inosine 5′-monophosphate cyclohydrolase   Cytoplasm             Enzyme                    −1.068
  B4DIT7       TGM2       Transglutaminase 2                                                                                        Cytoplasm             Enzyme                    −1.066
  E9PRQ6       ACAT1      Acetyl-CoA acetyltransferase 1                                                                            Cytoplasm             Enzyme                    −1.065
  C9JPM4       ARF4       ADP-ribosylation factor 4                                                                                 Cytoplasm             Other                     −1.059
  B1AH77       RAC2       Ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)                   Cytoplasm             Enzyme                    −1.053
  G3V3I1       PSMA6      Proteasome (prosome, macropain) subunit, α type, 6                                                        Cytoplasm             Peptidase                 −1.049
  B4DVU3       EIF3C      Eukaryotic translation initiation factor 3, subunit C                                                     Other                 Translation regulator     −1.047
  B4DKM5       VDAC2      Voltage-dependent anion channel 2                                                                         Cytoplasm             Ion channel               −1.045
  B4DEM7       CCT8       Chaperonin containing TCP1, subunit 8 (theta)                                                             Cytoplasm             Enzyme                    −1.044
  F5GX39       TMED2      Transmembrane emp24 domain trafficking protein 2                                                          Cytoplasm             Transporter               −1.043
  F5GZ27       LONP1      Lon peptidase 1, mitochondrial                                                                            Cytoplasm             Peptidase                 −1.041
  F5H667       ASPH       Aspartate β-hydroxylase                                                                                   Cytoplasm             Enzyme                    −1.040
  C9JLU1       POLR2H     Polymerase (RNA) II (DNA-directed) polypeptide H                                                          Nucleus               Enzyme                    −1.040
  B4DR70       FUS        Fused in sarcoma                                                                                          Nucleus               Transcription regulator   −1.039
  E7ETK5       IMPDH2     Inosine 5′-monophosphate dehydrogenase 2                                                                  Cytoplasm             Enzyme                    −1.038
  B4DXW1       ACTR3      ARP3 actin-related protein 3 homolog (yeast)                                                              Plasma membrane       Other                     −1.037
  F8VNT9       CD63       CD63 molecule                                                                                             Plasma membrane       Other                     −1.036
  E9PKZ0       RPL8       Ribosomal protein L8                                                                                      Other                 Other                     −1.036
  B7Z6A4       SURF4      Surfeit 4                                                                                                 Cytoplasm             Other                     −1.036
  F5H1S2       RPL13      Ribosomal protein L13                                                                                     Cytoplasm             Other                     −1.034
  B4DRF4       PTPLAD1    Protein tyrosine phosphatase-like A domain containing 1                                                   Cytoplasm             Other                     −1.028
  B4DZP4       DYNC1LI2   Dynein, cytoplasmic 1, light intermediate chain 2                                                         Cytoplasm             Other                     −1.024
  B3KQT9       PDIA3      Protein disulfide isomerase family A, member 3                                                            Cytoplasm             Peptidase                 −1.024
  E5RJR5       SKP1       S-phase kinase-associated protein 1                                                                       Nucleus               Transcription regulator   −1.024
  C9JV57       BZW1       Basic leucine zipper and W2 domains 1                                                                     Cytoplasm             Translation regulator     −1.022
  B4DUR8       CCT3       Chaperonin containing TCP1, subunit 3 (γ)                                                                 Cytoplasm             Other                     −1.022
  A8K3Z3       PSMC5      Proteasome (prosome, macropain) 26S subunit, ATPase, 5                                                    Nucleus               Transcription regulator   −1.022
  F5H8J3       CLPTM1     Cleft lip and palate associated transmembrane protein 1                                                   Plasma membrane       Other                     −1.021
  B7Z4V2       HSPA9      Heat shock 70 kDa protein 9 (mortalin)                                                                    Cytoplasm             Other                     −1.020
  F5GY50       PTGR1      Prostaglandin reductase 1                                                                                 Cytoplasm             Enzyme                    −1.015
  B4DPJ8       CCT6A      Chaperonin containing TCP1, subunit 6A (ζ 1)                                                              Cytoplasm             Other                     −1.014
  D6RG13       RPS3A      Ribosomal protein S3A                                                                                     Nucleus               Other                     −1.013
  C9JTK6       OLA1       Obg-like ATPase 1                                                                                         Cytoplasm             Other                     −1.011
  F8VRG3       TWF1       Twinfilin actin-binding protein 1                                                                         Cytoplasm             Kinase                    −1.007
  C9JZ20       PHB        Prohibitin                                                                                                Nucleus               Transcription regulator   −1.006
  C9JB50       RPL28      Ribosomal protein L28                                                                                     Cytoplasm             Other                     −1.006
  B7Z795       CES1       Carboxylesterase 1                                                                                        Cytoplasm             Enzyme                    −1.005
  F5GYN4       OTUB1      OTU deubiquitinase, ubiquitin aldehyde binding 1                                                          Cytoplasm             Enzyme                    −1.005
  B7Z4T9       CCT7       Chaperonin containing TCP1, subunit 7 (eta)                                                               Cytoplasm             Other                     −1.004
  B4DGN5       GLUD1      Glutamate dehydrogenase 1                                                                                 Cytoplasm             Enzyme                    −1.004
  B4DDF7       PPP2R1A    Protein phosphatase 2, regulatory subunit A, alpha                                                        Cytoplasm             Phosphatase               1.002
  B4DLR8       NQO1       NAD(P)H dehydrogenase, quinone 1                                                                          Cytoplasm             Enzyme                    1.005
  A6NLM8       SSR4       Signal sequence receptor, delta                                                                           Cytoplasm             Other                     1.008
  C9J7S3       DARS       Aspartyl-tRNA synthetase                                                                                  Cytoplasm             Enzyme                    1.009
  D6RAN4       RPL9       Ribosomal protein L9                                                                                      Cytoplasm             Other                     1.010
  B4E3C2       RPL17      Ribosomal protein L17                                                                                     Cytoplasm             Other                     1.012
  G3V279       ERH        Enhancer of rudimentary homolog (Drosophila)                                                              Nucleus               Other                     1.017
  B4DDG1       UBE2L3     Ubiquitin-conjugating enzyme E2L 3                                                                        Nucleus               Enzyme                    1.020
  C9JCK5       PSMA2      Proteasome (prosome, macropain) subunit, alpha type, 2                                                    Cytoplasm             Peptidase                 1.022
  E9PQD7       RPS2       Ribosomal protein S2                                                                                      Cytoplasm             Other                     1.023
  E7EX53       RPL15      Ribosomal protein L15                                                                                     Cytoplasm             Other                     1.024
  B7ZAT2       CCT2       Chaperonin containing TCP1, subunit 2 (β)                                                                 Cytoplasm             Kinase                    1.026
  E9PCY7       HNRNPH1    Heterogeneous nuclear ribonucleoprotein H1 (H)                                                            Nucleus               Other                     1.026
  B8ZZQ6       PTMA       α-prothymosin                                                                                             Nucleus               Other                     1.027
  B4E335       ACTB       β-actin                                                                                                   Cytoplasm             Other                     1.029
  A6NL93       HMGN1      High mobility group nucleosome binding domain 1                                                           Nucleus               Transcription regulator   1.029
  Q5JR95       RPS8       Ribosomal protein S8                                                                                      Cytoplasm             Other                     1.031
  C9J9K3       RPSA       Ribosomal protein SA                                                                                      Cytoplasm             Translation regulator     1.031
  C9JF49       XPO1       Exportin 1                                                                                                Nucleus               Transporter               1.033
  E9PGI8       CMPK1      Cytidine monophosphate (UMP-CMP) kinase 1, cytosolic                                                      Nucleus               Kinase                    1.034
  E9PMD7       PPP1CA     Protein phosphatase 1, catalytic subunit, alpha isozyme                                                   Cytoplasm             Phosphatase               1.035
  G3V3T3       ACIN1      Apoptotic chromatin condensation inducer 1                                                                Nucleus               Enzyme                    1.038
  B1ALW1       TXN        Thioredoxin                                                                                               Cytoplasm             Enzyme                    1.040
  A8MUD9       RPL7       Ribosomal protein L7                                                                                      Nucleus               Transcription regulator   1.041
  Q2YDB7       PPIF       Peptidylprolyl isomerase F                                                                                Cytoplasm             Enzyme                    1.042
  B7Z9L0       CCT4       Chaperonin containing TCP1, subunit 4 (δ)                                                                 Cytoplasm             Other                     1.045
  E7EQR4       EZR        Ezrin                                                                                                     Plasma membrane       Other                     1.046
  F8W118       NAP1L1     Nucleosome assembly protein 1-like 1                                                                      Nucleus               Other                     1.051
  F8VZJ2       NACA       Nascent polypeptide-associated complex α subunit                                                          Cytoplasm             Transcription regulator   1.055
  G3V5B3       ERO1L      ERO1-like (*Saccharomyces cerevisiae*)                                                                    Cytoplasm             Enzyme                    1.058
  B4E2S7       LAMP2      Lysosomal-associated membrane protein 2                                                                   Plasma membrane       Enzyme                    1.060
  B4DR63       PSMC1      Proteasome (prosome, macropain) 26S subunit, ATPase, 1                                                    Nucleus               Peptidase                 1.060
  G3V5M3       DLST       Dihydrolipoamide *S*-succinyltransferase                                                                  Cytoplasm             Enzyme                    1.061
  C9JU56       RPL31      Ribosomal protein L31                                                                                     Cytoplasm             Other                     1.061
  B7Z1N6       ALDOC      Aldolase C, fructose-bisphosphate                                                                         Cytoplasm             Enzyme                    1.062
  F8VWC5       RPL18      Ribosomal protein L18                                                                                     Cytoplasm             Other                     1.064
  C9JD32       RPL23      Ribosomal protein L23                                                                                     Cytoplasm             Other                     1.066
  A4D177       CBX3       Chromobox homolog 3                                                                                       Nucleus               Transcription regulator   1.068
  Q5HYE7       CRYZ       ζ-Crystallin, (quinone reductase)                                                                         Cytoplasm             Enzyme                    1.069
  B4E3E8       DDX3X      DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked                                                           Cytoplasm             Enzyme                    1.072
  A8K8G0       HDGF       Hepatoma-derived growth factor                                                                            Extracellular space   Growth factor             1.074
  F5H897       TRAP1      Tumor necrosis factor receptor-associated protein 1                                                       Cytoplasm             Enzyme                    1.074
  E9PNR9       PRMT1      Protein arginine methyltransferase 1                                                                      Nucleus               Enzyme                    1.075
  E9PJH8       SERPINH1   Serpin peptidase inhibitor, clade H (heat shock protein 47), member 1                                     Extracellular space   Other                     1.075
  C9JKI3       CAV1       Caveolin 1, caveolae protein, 22 kDa                                                                      Plasma membrane       Transmembrane receptor    1.078
  D6R9P3       HNRNPAB    Heterogeneous nuclear ribonucleoprotein A/B                                                               Nucleus               Enzyme                    1.081
  Q8N1C0       CTNNA1     Catenin (cadherin-associated protein), α1, 102 kDa                                                        Plasma membrane       Other                     1.084
  B4DY66       SAE1       SUMO1 activating enzyme subunit 1                                                                         Cytoplasm             Enzyme                    1.087
  F6RFD5       DSTN       Destrin (actin depolymerizing factor)                                                                     Cytoplasm             Other                     1.088
  C9J712       PFN2       Profilin 2                                                                                                Cytoplasm             Other                     1.088
  F5H4D6       G3BP1      GTPase activating protein (SH3 domain) binding protein 1                                                  Nucleus               Enzyme                    1.091
  B4DR31       DPYSL2     Dihydropyrimidinase-like 2                                                                                Cytoplasm             Enzyme                    1.092
  B6EAT9       CD44       CD44 molecule (Indian blood group)                                                                        Plasma membrane       Enzyme                    1.097
  B4E3S0       CORO1C     Coronin, actin binding protein, 1C                                                                        Cytoplasm             Other                     1.108
  C9JHS6       AKT2       V-akt murine thymoma viral oncogene homolog 2                                                             Cytoplasm             Kinase                    1.116
  Q5TA01       GSTO1      Glutathione S-transferase ω1                                                                              Cytoplasm             Enzyme                    1.119
  F8W7C6       RPL10      Ribosomal protein L10                                                                                     Cytoplasm             Other                     1.124
  F5H0T1       STIP1      Stress-induced phosphoprotein 1                                                                           Cytoplasm             Other                     1.127
  C9JFR7       CYCS       Cytochrome c, somatic                                                                                     Cytoplasm             Transporter               1.128
  E7EPB3       RPL14      Ribosomal protein L14                                                                                     Cytoplasm             Other                     1.129
  F5H6Q2       UBC        Ubiquitin C                                                                                               Cytoplasm             Enzyme                    1.131
  B4DP24       ELOVL1     ELOVL fatty acid elongase 1                                                                               Cytoplasm             Enzyme                    1.135
  B3KS31       TUBB6      Tubulin, β6 class V                                                                                       Cytoplasm             Other                     1.136
  B7Z9C4       CTPS1      CTP synthase 1                                                                                            Nucleus               Enzyme                    1.144
  F8W0G4       PCBP2      Poly(rC) binding protein 2                                                                                Nucleus               Other                     1.146
  F8WBE5       TFRC       Transferrin receptor                                                                                      Plasma membrane       Transporter               1.147
  B7Z2S5       TXNRD1     Thioredoxin reductase 1                                                                                   Cytoplasm             Enzyme                    1.153
  B2RDM2       TXNDC5     Thioredoxin domain containing 5 (endoplasmic reticulum)                                                   Cytoplasm             Enzyme                    1.154
  B4DSC0       TNPO1      Transportin 1                                                                                             Nucleus               Transporter               1.155
  F8VPF3       MYL6       Myosin, light chain 6, alkali, smooth muscle and non-muscle                                               Cytoplasm             Other                     1.156
  B0V3J0       TSEN34     TSEN34 tRNA splicing endonuclease subunit                                                                 Nucleus               Enzyme                    1.159
  F8VR50       ARPC3      Actin related protein 2/3 complex, subunit 3, 21 kDa                                                      Cytoplasm             Other                     1.162
  B3KTM6       RPL5       Ribosomal protein L5                                                                                      Cytoplasm             Other                     1.165
  Q5H907       MAGED2     Melanoma antigen family D, 2                                                                              Plasma membrane       Other                     1.168
  Q75MH1       RPS26      Ribosomal protein S26                                                                                     Cytoplasm             Other                     1.181
  B4DZI8       COPB2      Coatomer protein complex, subunit beta 2 (β prime)                                                        Cytoplasm             Transporter               1.182
  Q5T4L4       RPS27      Ribosomal protein S27                                                                                     Cytoplasm             Other                     1.183
  Q5T093       RER1       Retention in endoplasmic reticulum sorting receptor 1                                                     Cytoplasm             Other                     1.188
  Q5VU59       TPM3       Tropomyosin 3                                                                                             Cytoplasm             Other                     1.198
  Q5T7C4       HMGB1      High mobility group box 1                                                                                 Nucleus               Other                     1.216
  C9JFK9       BAG3       Bcl2-associated athanogene 3                                                                              Cytoplasm             Other                     1.219
  G3V153       CAPRIN1    Cell cycle associated protein 1                                                                           Plasma membrane       Other                     1.223
  E5RHS5       EIF3E      Eukaryotic translation initiation factor 3, subunit E                                                     Cytoplasm             Other                     1.228
  B7Z8D3       PSME3      Proteasome (prosome, macropain) activator subunit 3 (PA28 γ; Ki)                                          Cytoplasm             Peptidase                 1.242
  B4E2Z3       SLC3A2     Solute carrier family 3 (amino acid transporter heavy chain), member 2                                    Plasma membrane       Transporter               1.247
  E9PP21       CSRP1      Cysteine and glycine-rich protein 1                                                                       Nucleus               Other                     1.250
  B4DMT5       EIF3F      Eukaryotic translation initiation factor 3, subunit F                                                     Cytoplasm             Translation regulator     1.263
  C9K0U8       SSBP1      Single-stranded DNA binding protein 1, mitochondrial                                                      Cytoplasm             Other                     1.271
  A8MUB1       TUBA4A     α-tubulin, 4a                                                                                             Cytoplasm             Other                     1.298
  C9IZ41       ZYX        Zyxin                                                                                                     Plasma membrane       Other                     1.326
  F5H4W0       ME1        Malic enzyme 1, NADP^+^-dependent, cytosolic                                                              Cytoplasm             Enzyme                    1.331
  B4DPJ6       TPD52L2    Tumor protein D52-like 2                                                                                  Cytoplasm             Other                     1.340
  F5H0C8       ENO2       γ-enolase 2 (neuronal)                                                                                    Cytoplasm             Enzyme                    1.347
  C9JL85       MTPN       Myotrophin                                                                                                Nucleus               Transcription regulator   1.514
  B4DP11       PTGES3     Prostaglandin E synthase 3 (cytosolic)                                                                    Cytoplasm             Enzyme                    1.801

###### 

Networks of potential molecular targets regulated by DMXAA (5,6-dimethylxanthenone 4-acetic acid) in A549 cells

  ID   Molecules in network                                                                                                                                                                                                                                                                                                             Score   Focus molecules   Top diseases and functions
  ---- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------- ----------------- --------------------------------------------------------------------------------------------------------
  1    ASPH, ATIC, BZW1, CHORDC1, CLPTM1, CMPK1, CRYZ, CYB5B, DYNC1LI2, ELOVL1, GANAB, H2AFV, ME1, OLA1, PAICS, PDIA6, PGD, PRKCSH, PTGR1, RER1, SAE1, SFXN1, SLC25A3, SLC25A11, SLC6A6, SSBP1, STOM, SUCLG2, SURF4, SYCP1, TMED2, TPD52L2, TSEN34, TXNDC5, UBC                                                                         77      35                Carbohydrate metabolism, small molecule biochemistry, lipid metabolism
  2    60S ribosomal subunit, ACIN1, Akt, CD63, DDX3X, EIF3, EIF3C, EIF3E, EIF3F, EIF4B, histone H1, HNRNPF, β-importin, IPO5, MTORC2, NEDD8, Rar, RPL5, RPL7, RPL9, RPL10, RPL13, RPL14, RPL15, RPL17, RPL18, RPL23, RPL28, RPL31, RPL7A, SLC3A2, thymidine kinase, TNPO1, TPM3, TRAP1                                                 52      27                Gene expression, protein synthesis, cancer
  3    APEX1, ARF4, ARPC3, collagen type I, cytochrome C, ERK, ETFA, HDGF, HISTONE, HMGB1, HMGN1, HNRNPD, Hsp27, mitochondrial complex 1, NACA, NAP1L1, PHB, PLS3, PP2A, PPP2R1A, PRDX3, PRMT1, PTMA, ribosomal 40s subunit, RNR, RPS2, RPS8, RPS26, RPS27, RPS3A, RPSA, STOML2, TCF, VDAC2, XPO1                                       47      25                Cellular response to therapeutics, connective tissue development and function, carbohydrate metabolism
  4    19S proteasome, 20s proteasome, 26s proteasome, α-tubulin, ATPase, BAG3, β-tubulin, CCT2, CCT3, CCT4, CCT7, CCT8, CCT6A, FUBP1, GSR, IκB, immunoproteasome Pa28/20s, LAMP2, LONP1, MTPN, NF-κB (complex), NQO1, PEBP1, proteasome PA700/20s, PSMA, PSMA1, PSMA2, PSMA6, PSMC1, PSMC5, PSMD14, PSME3, PTPLAD1, TUBB6, ubiquitin   41      23                Cell death and survival, DNA replication, recombination, and repair, energy production
  5    ACTB, actin, ACTR1A, α-actinin, CAPRIN1, CFL2, cofilin, DARS, DLST, DPYSL2, DSTN, ERK1/2, Erm, EZR, F-actin, gilamin, G-actin, G3BP1, GLUD1, Na^+^, K^+^-ATPase, PCBP2, PFN2, PKG, profilin, proinsulin, Rho GDI, Rock, RPL8, RTN4, SRSF3, thioredoxin reductase, TLN1, TWF1, TXNRD1, ZYX                                        34      20                Cellular assembly and organization, cellular compromise, cellular function and maintenance
  6    ALDOC, ATP6V1A, ATP6V1E2, BIN3, BTF3L4, CORO1C, DDB1, DNAJB3, DNAJC16, DNAJC22, DNAJC28, ERH, GRPEL2, GTF2H2C_2, HNRNPAB, HNRNPH1, HSPA9, MATR3, OTUB1, PAGE1, PCDHAC2, POLR2H, POLR2J2/POLR2J3, PPIF, RDM1, RPN1, SERPINH1, SPAG7, SSR4, STON1-GTF2A1L, TARBP1, TBP, TMEM106B, tubulin (complex), UBC                           25      16                Gene expression, cell morphology, cellular assembly and organization
  7    ACAT1, ADCY, AMPK, CA12, calmodulin, caspase, CK2, Creb, CSRP1, CTSD, cyclin A, CYCS, ERO1L, estrogen receptor, FUS, Hsp70, Hsp90, IL1, IMPDH2, insulin, Lh, MYL6, NOS, PDIA3, PI3K (complex), PLC, PTGES3, Rb, RNA polymerase II, STIP1, TGM2, thyroid hormone receptor, TUBA4A, tubulin (family), TXN                          23      15                Neurological disease, skeletal and muscular disorders, cell death and survival
  8    ACTR3, α-catenin, ARCN1, CBX3, CD3, COPB2, CTNNA1, CTPS1, hemoglobin, histone H3, histone H4, IFN-β, IgG, IL12 (complex), immunoglobulin, interferon-α, MAGED2, MAPK, mediator, NMDA receptor, p38 MAPK, PKA, PKC(s), PLC-γ, RARS, Ras homolog, SFK, SRC (family), STAT5a/b, TFRC, TNF (family), trypsin, VEGF, WDHD1            14      10                Infectious disease, cardiac damage, cardiac fibrosis
  9    AKT2, AP1, BCR (complex), calpain, CAV1, CD44, collagen(s), ENO2, fibrinogen, focal adhesion kinase, IGM, integrin, JNK, laminin, LDH (complex), LDL, LFA-1, MEK, NADPH oxidase, NFAT (family), p85 (PI3K), PDGF (complex), PDGF BB, PI3K (family), Pld, Rac, RAC2, Ras, RHOA, SOD, SOD2, SOS, TGF-β, TKT, tyrosine kinase       10      8                 Free radical scavenging, cell morphology, cellular assembly and organization
  10   APP, CENPI, CEP250, CES1, CHCHD6, CMAS, CPLX2, DDX10, ERBB2, FBXL7, FBXL20, FBXW9, FSH, GNLY, GNRH2, GPR12, GSK3, GSPT2, GSTO1, MTORC1, NDP, PCIF1, PDXP, PPFIA4, PPP1CA, PPP1R32, PRR16, RGL1, SH3BGRL3, SKP1, SSH3, TSKS, UBE2L3, ZC3HC1, ZFYVE1                                                                               7       6                 Cell morphology, cellular function and maintenance, cardiovascular system development and function

[^1]: \*These two authors contributed equally to this work
